
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Low‐Dose Hydrocortisone in Cirrhotic Patients With Septic Shock: A Double‐Blind Randomised Placebo‐Controlled Trial - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="D2E4813E8AEEC3D305813E003D0C7709.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="blackwellopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12320571/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Liver International">
<meta name="citation_title" content="Low‐Dose Hydrocortisone in Cirrhotic Patients With Septic Shock: A Double‐Blind Randomised Placebo‐Controlled Trial">
<meta name="citation_author" content="Philippe Meersseman">
<meta name="citation_author_institution" content="Medical Intensive Care Unit, Department of General Internal Medicine, University Hospital Leuven, Leuven, Belgium">
<meta name="citation_author" content="María Hernández‐Tejero">
<meta name="citation_author_institution" content="Liver ICU, Liver Unit, IDIBAPS and CIBERehd, Hospital Clinic, Barcelona, Spain">
<meta name="citation_author_institution" content="Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA">
<meta name="citation_author" content="Juan Manuel Diaz">
<meta name="citation_author_institution" content="EF Clif, EASL‐CLIF Consortium, Barcelona, Spain">
<meta name="citation_author" content="Joost Wauters">
<meta name="citation_author_institution" content="Medical Intensive Care Unit, Department of General Internal Medicine, University Hospital Leuven, Leuven, Belgium">
<meta name="citation_author" content="Greet Hermans">
<meta name="citation_author_institution" content="Medical Intensive Care Unit, Department of General Internal Medicine, University Hospital Leuven, Leuven, Belgium">
<meta name="citation_author" content="Fátima Aziz">
<meta name="citation_author_institution" content="Liver ICU, Liver Unit, IDIBAPS and CIBERehd, Hospital Clinic, Barcelona, Spain">
<meta name="citation_author" content="Helga Ceunen">
<meta name="citation_author_institution" content="Medical Intensive Care Unit, Department of General Internal Medicine, University Hospital Leuven, Leuven, Belgium">
<meta name="citation_author" content="Veronica Prado">
<meta name="citation_author_institution" content="Liver ICU, Liver Unit, IDIBAPS and CIBERehd, Hospital Clinic, Barcelona, Spain">
<meta name="citation_author_institution" content="Hepato‐Gastroenterology, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg">
<meta name="citation_author" content="Lies Langouche">
<meta name="citation_author_institution" content="Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium">
<meta name="citation_author" content="Mireya Arteaga">
<meta name="citation_author_institution" content="Liver ICU, Liver Unit, IDIBAPS and CIBERehd, Hospital Clinic, Barcelona, Spain">
<meta name="citation_author" content="Juan Acevedo">
<meta name="citation_author_institution" content="Gastroenterology Department, University Hospital Plymouth, Plymouth, UK">
<meta name="citation_author" content="Marc Lleixa">
<meta name="citation_author_institution" content="Liver ICU, Liver Unit, IDIBAPS and CIBERehd, Hospital Clinic, Barcelona, Spain">
<meta name="citation_author" content="Juliana Zapatero">
<meta name="citation_author_institution" content="Liver ICU, Liver Unit, IDIBAPS and CIBERehd, Hospital Clinic, Barcelona, Spain">
<meta name="citation_author" content="David Toapanta">
<meta name="citation_author_institution" content="Liver ICU, Liver Unit, IDIBAPS and CIBERehd, Hospital Clinic, Barcelona, Spain">
<meta name="citation_author" content="Vicente Arroyo">
<meta name="citation_author_institution" content="EF Clif, EASL‐CLIF Consortium, Barcelona, Spain">
<meta name="citation_author" content="Alexander Wilmer">
<meta name="citation_author_institution" content="Medical Intensive Care Unit, Department of General Internal Medicine, University Hospital Leuven, Leuven, Belgium">
<meta name="citation_author" content="Javier Fernandez">
<meta name="citation_author_institution" content="Liver ICU, Liver Unit, IDIBAPS and CIBERehd, Hospital Clinic, Barcelona, Spain">
<meta name="citation_author_institution" content="EF Clif, EASL‐CLIF Consortium, Barcelona, Spain">
<meta name="citation_author_institution" content="Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain">
<meta name="citation_publication_date" content="2025 Aug 4">
<meta name="citation_volume" content="45">
<meta name="citation_issue" content="9">
<meta name="citation_firstpage" content="e70257">
<meta name="citation_doi" content="10.1111/liv.70257">
<meta name="citation_pmid" content="40757786">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12320571/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12320571/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12320571/pdf/LIV-45-0.pdf">
<meta name="description" content="Steroid supplementation remains controversial in septic shock, partly due to the heterogeneity of the populations studied. Cirrhotic patients with sepsis frequently develop relative adrenal insufficiency, showing poor response to vasopressors and ...">
<meta name="og:title" content="Low‐Dose Hydrocortisone in Cirrhotic Patients With Septic Shock: A Double‐Blind Randomised Placebo‐Controlled Trial">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Steroid supplementation remains controversial in septic shock, partly due to the heterogeneity of the populations studied. Cirrhotic patients with sepsis frequently develop relative adrenal insufficiency, showing poor response to vasopressors and ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12320571/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12320571">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1111/liv.70257"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/LIV-45-0.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12320571%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12320571/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12320571/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12320571/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-blackwellopen.png" alt="Wiley Open Access Collection logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Wiley Open Access Collection" title="Link to Wiley Open Access Collection" shape="default" href="https://doi.org/10.1111/liv.70257" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Liver Int</button></div>. 2025 Aug 4;45(9):e70257. doi: <a href="https://doi.org/10.1111/liv.70257" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1111/liv.70257</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Liver%20Int%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liver%20Int%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Liver%20Int%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Liver%20Int%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Low‐Dose Hydrocortisone in Cirrhotic Patients With Septic Shock: A Double‐Blind Randomised Placebo‐Controlled Trial</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Meersseman%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Philippe Meersseman</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Philippe Meersseman</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Medical Intensive Care Unit, Department of General Internal Medicine, University Hospital Leuven, Leuven, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Meersseman%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Philippe Meersseman</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hern%C3%A1ndez%E2%80%90Tejero%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">María Hernández‐Tejero</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">María Hernández‐Tejero</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Liver ICU, Liver Unit, IDIBAPS and CIBERehd, Hospital Clinic, Barcelona, Spain</div>
<div class="p">
<sup>
<sup>3</sup>
</sup>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hern%C3%A1ndez%E2%80%90Tejero%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">María Hernández‐Tejero</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Diaz%20JM%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Juan Manuel Diaz</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Juan Manuel Diaz</span></h3>
<div class="p">
<sup>
<sup>4</sup>
</sup>EF Clif, EASL‐CLIF Consortium, Barcelona, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Diaz%20JM%22%5BAuthor%5D" class="usa-link"><span class="name western">Juan Manuel Diaz</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wauters%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Joost Wauters</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Joost Wauters</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Medical Intensive Care Unit, Department of General Internal Medicine, University Hospital Leuven, Leuven, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wauters%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Joost Wauters</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hermans%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Greet Hermans</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Greet Hermans</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Medical Intensive Care Unit, Department of General Internal Medicine, University Hospital Leuven, Leuven, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hermans%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Greet Hermans</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Aziz%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Fátima Aziz</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Fátima Aziz</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Liver ICU, Liver Unit, IDIBAPS and CIBERehd, Hospital Clinic, Barcelona, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Aziz%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Fátima Aziz</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ceunen%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Helga Ceunen</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Helga Ceunen</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Medical Intensive Care Unit, Department of General Internal Medicine, University Hospital Leuven, Leuven, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ceunen%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Helga Ceunen</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Prado%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Veronica Prado</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Veronica Prado</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Liver ICU, Liver Unit, IDIBAPS and CIBERehd, Hospital Clinic, Barcelona, Spain</div>
<div class="p">
<sup>
<sup>5</sup>
</sup>Hepato‐Gastroenterology, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Prado%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Veronica Prado</span></a>
</div>
</div>
<sup>2,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Langouche%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Lies Langouche</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Lies Langouche</span></h3>
<div class="p">
<sup>
<sup>6</sup>
</sup>Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Langouche%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lies Langouche</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Arteaga%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Mireya Arteaga</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Mireya Arteaga</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Liver ICU, Liver Unit, IDIBAPS and CIBERehd, Hospital Clinic, Barcelona, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Arteaga%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mireya Arteaga</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Acevedo%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Juan Acevedo</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Juan Acevedo</span></h3>
<div class="p">
<sup>
<sup>7</sup>
</sup>Gastroenterology Department, University Hospital Plymouth, Plymouth, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Acevedo%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Juan Acevedo</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lleixa%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Marc Lleixa</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Marc Lleixa</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Liver ICU, Liver Unit, IDIBAPS and CIBERehd, Hospital Clinic, Barcelona, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lleixa%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marc Lleixa</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zapatero%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Juliana Zapatero</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Juliana Zapatero</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Liver ICU, Liver Unit, IDIBAPS and CIBERehd, Hospital Clinic, Barcelona, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zapatero%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Juliana Zapatero</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Toapanta%20D%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">David Toapanta</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">David Toapanta</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Liver ICU, Liver Unit, IDIBAPS and CIBERehd, Hospital Clinic, Barcelona, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Toapanta%20D%22%5BAuthor%5D" class="usa-link"><span class="name western">David Toapanta</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Arroyo%20V%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Vicente Arroyo</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Vicente Arroyo</span></h3>
<div class="p">
<sup>
<sup>4</sup>
</sup>EF Clif, EASL‐CLIF Consortium, Barcelona, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Arroyo%20V%22%5BAuthor%5D" class="usa-link"><span class="name western">Vicente Arroyo</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wilmer%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Alexander Wilmer</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Alexander Wilmer</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Medical Intensive Care Unit, Department of General Internal Medicine, University Hospital Leuven, Leuven, Belgium</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wilmer%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alexander Wilmer</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fernandez%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Javier Fernandez</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Javier Fernandez</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Liver ICU, Liver Unit, IDIBAPS and CIBERehd, Hospital Clinic, Barcelona, Spain</div>
<div class="p">
<sup>
<sup>4</sup>
</sup>EF Clif, EASL‐CLIF Consortium, Barcelona, Spain</div>
<div class="p">
<sup>
<sup>8</sup>
</sup>Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fernandez%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Javier Fernandez</span></a>
</div>
</div>
<sup>2,</sup><sup>4,</sup><sup>8,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="liv70257-aff-0001">
<sup>
<sup>1</sup>
</sup>Medical Intensive Care Unit, Department of General Internal Medicine, University Hospital Leuven, Leuven, Belgium</div>
<div id="liv70257-aff-0002">
<sup>
<sup>2</sup>
</sup>Liver ICU, Liver Unit, IDIBAPS and CIBERehd, Hospital Clinic, Barcelona, Spain</div>
<div id="liv70257-aff-0003">
<sup>
<sup>3</sup>
</sup>Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA</div>
<div id="liv70257-aff-0004">
<sup>
<sup>4</sup>
</sup>EF Clif, EASL‐CLIF Consortium, Barcelona, Spain</div>
<div id="liv70257-aff-0005">
<sup>
<sup>5</sup>
</sup>Hepato‐Gastroenterology, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg</div>
<div id="liv70257-aff-0006">
<sup>
<sup>6</sup>
</sup>Clinical Division and Laboratory of Intensive Care Medicine, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium</div>
<div id="liv70257-aff-0007">
<sup>
<sup>7</sup>
</sup>Gastroenterology Department, University Hospital Plymouth, Plymouth, UK</div>
<div id="liv70257-aff-0008">
<sup>
<sup>8</sup>
</sup>Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Javier Fernandez (<span>jfdez@clinic.cat</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Jun 20; Received 2025 Feb 19; Accepted 2025 Jul 24; Issue date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Liver International</em> published by John Wiley &amp; Sons Ltd.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12320571  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40757786/" class="usa-link">40757786</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<section id="liv70257-sec-0001"><h3 class="pmc_sec_title">Background and Aims</h3>
<p>Steroid supplementation remains controversial in septic shock, partly due to the heterogeneity of the populations studied. Cirrhotic patients with sepsis frequently develop relative adrenal insufficiency, showing poor response to vasopressors and poor prognosis. Early administration of low‐dose hydrocortisone might facilitate shock reversal and reduce mortality in this population.</p></section><section id="liv70257-sec-0002"><h3 class="pmc_sec_title">Methods</h3>
<p>Double‐blind, randomised, placebo‐controlled multicentre trial, enrolling adult cirrhotic patients with septic shock. Patients were assigned to receive i.v. hydrocortisone (100 mg followed by a continuous infusion of 200 mg/24 h) or placebo, for at least 3 days, followed by a tapering period of 3–7 days, depending on the time of shock resolution. Primary endpoint was 28‐day all‐cause mortality.</p></section><section id="liv70257-sec-0003"><h3 class="pmc_sec_title">Results</h3>
<p>After enrolment of 83 patients the trial was stopped early due to slow inclusions. Most patients required low‐to‐moderate doses of vasopressors. There was no difference in 28‐day mortality (35% vs. 39.5%; <em>p</em> = 0.84) between hydrocortisone and placebo groups. Shock resolution (85% vs. 72.1%; <em>p</em> = 0.25) and days to shock resolution [3 days (2.2–4; IQR) vs. 4 (2–7.5; IQR)] were also similar between groups. More patients receiving placebo died of refractory shock (47.6% vs. 8.7%). No significant differences between treatment arms were observed in shock relapse, new shock episodes or bacterial or fungal superinfections during hospital stay. Hypo‐ and hyperglycaemias were more frequent in the hydrocortisone arm. Severity of ACLF at inclusion and inadequacy of empirical antibiotic therapy (HR = 6.40; 95% CI: 3.21–12.79) independently predicted 28‐day mortality.</p></section><section id="liv70257-sec-0004"><h3 class="pmc_sec_title">Conclusions</h3>
<p>Supplemental hydrocortisone did not improve short‐term survival in cirrhotic patients with septic shock requiring low‐to‐moderate doses of vasopressors.</p></section><section id="liv70257-sec-0005"><h3 class="pmc_sec_title">Trial Registration</h3>
<p>S‐number University Hospitals Leuven, Belgium: <a href="https://www.ncbi.nlm.nih.gov/protein/S55168" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">S55168</a>; EUDRACT: 2010–024273‐38; Clinicaltrials.gov id: <a href="https://clinicaltrials.gov/ct2/show/NCT02602210" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02602210</a></p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> ACLF, mortality, refractory shock, safety, shock reversal</p></section></section><hr class="headless">
<h3>Abbreviations</h3>
<dl class="def-list" id="liv70257-dl-0001">
<dt id="liv70257-li-0001">ACLF</dt>
<dd id="liv70257-li-0002"><p>acute‐on‐chronic liver failure</p></dd>
<dt id="liv70257-li-0003">ACTH</dt>
<dd id="liv70257-li-0004"><p>adrenocorticotropic hormone</p></dd>
<dt id="liv70257-li-0005">CBG</dt>
<dd id="liv70257-li-0006"><p>cortisol binding globulin</p></dd>
<dt id="liv70257-li-0007">CIF</dt>
<dd id="liv70257-li-0008"><p>cumulative incidence function</p></dd>
<dt id="liv70257-li-0009">CIRCI</dt>
<dd id="liv70257-li-0010"><p>critical illness related corticosteroid insufficiency</p></dd>
<dt id="liv70257-li-0011">HCS</dt>
<dd id="liv70257-li-0012"><p>hydrocortisone</p></dd>
<dt id="liv70257-li-0013">MAP</dt>
<dd id="liv70257-li-0014"><p>mean arterial pressure</p></dd>
<dt id="liv70257-li-0015">MDR</dt>
<dd id="liv70257-li-0016"><p>multidrug‐resistant</p></dd>
<dt id="liv70257-li-0017">(R)AI</dt>
<dd id="liv70257-li-0018"><p>(Relative) adrenal insufficiency</p></dd>
<dt id="liv70257-li-0019">RCT</dt>
<dd id="liv70257-li-0020"><p>randomised controlled trial</p></dd>
<dt id="liv70257-li-0021">RRT</dt>
<dd id="liv70257-li-0022"><p>renal replacement therapy</p></dd>
</dl>
<section class="bt xbox font-sm" id="liv70257-blkfxd-0001"><h2 class="obj_head">Summary.</h2>
<ul id="liv70257-list-0001" class="list" style="list-style-type:disc">
<li id="liv70257-li-0023"><p>Steroid supplementation remains controversial in septic shock, both in cirrhotic and non‐cirrhotic populations.</p></li>
<li id="liv70257-li-0024"><p>This double‐blind RCT showed no improvement in short‐term survival or shock reversal in cirrhotic patients with septic shock receiving supplemental low‐dose steroids. Since the study was not statistically powered, our findings should be interpreted with caution and considered inconclusive.</p></li>
<li id="liv70257-li-0025"><p>Severity of liver disease and of acute‐on‐chronic liver failure were major determinants of mortality together with the inadequacy of empirical antibiotic strategies.</p></li>
<li id="liv70257-li-0026"><p>The role of steroid supplementation in patients with high vasopressor requirements remains to be elucidated since only one third of our patients needed high norepinephrine doses (≥ 0.25 μg/kg/min) at inclusion.</p></li>
</ul></section><section id="liv70257-sec-0009"><h2 class="pmc_sec_title">1. Background</h2>
<p>Treatment of relative adrenal insufficiency (RAI) in septic shock is still a matter of debate [<a href="#liv70257-bib-0001" class="usa-link" aria-describedby="liv70257-bib-0001">1</a>] with several randomised controlled trials (RCTs) [<a href="#liv70257-bib-0002" class="usa-link" aria-describedby="liv70257-bib-0002">2</a>, <a href="#liv70257-bib-0003" class="usa-link" aria-describedby="liv70257-bib-0003">3</a>, <a href="#liv70257-bib-0004" class="usa-link" aria-describedby="liv70257-bib-0004">4</a>, <a href="#liv70257-bib-0005" class="usa-link" aria-describedby="liv70257-bib-0005">5</a>], systematic reviews, and meta‐analysis [<a href="#liv70257-bib-0006" class="usa-link" aria-describedby="liv70257-bib-0006">6</a>, <a href="#liv70257-bib-0007" class="usa-link" aria-describedby="liv70257-bib-0007">7</a>] showing conflicting results. Possible explanations are the lack of a universally accepted definition for the entity, evaluation of heterogenous populations, and the use of different treatment protocols (type of steroids/doses/duration). Moreover, novel insights into the pathophysiology of RAI further question the diagnostic tests and the beneficial effect of stress‐dose steroids [<a href="#liv70257-bib-0008" class="usa-link" aria-describedby="liv70257-bib-0008">8</a>, <a href="#liv70257-bib-0009" class="usa-link" aria-describedby="liv70257-bib-0009">9</a>, <a href="#liv70257-bib-0010" class="usa-link" aria-describedby="liv70257-bib-0010">10</a>].</p>
<p>Many studies have shown that a significant number of patients with cirrhosis develop RAI, especially in cases of sepsis (52%–77%) [<a href="#liv70257-bib-0011" class="usa-link" aria-describedby="liv70257-bib-0011">11</a>, <a href="#liv70257-bib-0012" class="usa-link" aria-describedby="liv70257-bib-0012">12</a>, <a href="#liv70257-bib-0013" class="usa-link" aria-describedby="liv70257-bib-0013">13</a>, <a href="#liv70257-bib-0014" class="usa-link" aria-describedby="liv70257-bib-0014">14</a>]. Its aetiology is multifactorial, including low HDL levels, substrate for adrenal steroidogenesis, and high pro‐inflammatory cytokines that suppress the hypothalamic–pituitary axis and reduce peripheral tissue glucocorticoid sensitivity [<a href="#liv70257-bib-0015" class="usa-link" aria-describedby="liv70257-bib-0015">15</a>]. Moreover, bile acids suppress cortisol metabolism, resulting in higher cortisol levels and chronic suppression of adrenal glands [<a href="#liv70257-bib-0009" class="usa-link" aria-describedby="liv70257-bib-0009">9</a>, <a href="#liv70257-bib-0016" class="usa-link" aria-describedby="liv70257-bib-0016">16</a>]. RAI impairs haemodynamic stability and contributes to the development of acute‐on‐chronic liver failure (ACLF) [<a href="#liv70257-bib-0017" class="usa-link" aria-describedby="liv70257-bib-0017">17</a>, <a href="#liv70257-bib-0018" class="usa-link" aria-describedby="liv70257-bib-0018">18</a>].</p>
<p>Although retrospective data [<a href="#liv70257-bib-0011" class="usa-link" aria-describedby="liv70257-bib-0011">11</a>, <a href="#liv70257-bib-0013" class="usa-link" aria-describedby="liv70257-bib-0013">13</a>] and recent consensus statements [<a href="#liv70257-bib-0019" class="usa-link" aria-describedby="liv70257-bib-0019">19</a>, <a href="#liv70257-bib-0020" class="usa-link" aria-describedby="liv70257-bib-0020">20</a>, <a href="#liv70257-bib-0021" class="usa-link" aria-describedby="liv70257-bib-0021">21</a>] suggest a possible beneficial effect of steroids in patients with cirrhosis and septic shock, large, randomised trials are lacking. Furthermore, since steroids may aggravate immune dysfunction in critically ill patients with cirrhosis, increasing the risk of infections, unreasoned use of steroids could be harmful.</p>
<p>Therefore, our objective was to investigate the clinical impact of treating this specific population with stress‐dose steroids in addition to standard medical therapy to reverse haemodynamic instability and organ failure and decrease mortality. The safety profile of steroids in this setting was also evaluated.</p></section><section id="liv70257-sec-0010"><h2 class="pmc_sec_title">2. Methods</h2>
<section id="liv70257-sec-0011"><h3 class="pmc_sec_title">2.1. Study Design</h3>
<p>Double‐blind, randomised, placebo‐controlled, multicentre trial, involving 3 European tertiary ICUs with expertise in the management of patients with cirrhosis. From 2015 to 2019 all adult patients with cirrhosis and septic shock [defined as sepsis requiring vasopressors despite adequate fluid resuscitation to achieve a mean arterial pressure (MAP) of &gt; 60 mmHg (&gt; 65 mmHg if signs of hypoperfusion)] were screened for inclusion (Figure <a href="#liv70257-fig-0001" class="usa-link">1</a>). Main exclusion criteria were vasopressor for &gt; 24 h, active GI bleeding, steroid/other immunosuppressive drug in the past 3 months, active malignancy, SOFA score &gt; 16 and recent use of etomidate among others (all exclusion criteria are shown in the Data <a href="#liv70257-supitem-0001" class="usa-link">S1</a>). Patients were randomised after providing written informed consent by the patient/legal representative if the patient lacked mental competency (with retrospective consent obtained from all patients who regained competency). The study was performed in the Medical ICU, University Hospitals Leuven, Belgium, the Liver ICU, Hospital Clinic Barcelona, Spain and University Hospital Plymouth NHS Trust, United Kingdom. The study was approved by local Ethical Committees (Leuven <a href="https://www.ncbi.nlm.nih.gov/protein/S55168" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">S55168</a>, Barcelona HCB/2014/0268, Plymouth 207 950). All authors had access to the study data and reviewed and approved the final manuscript.</p>
<figure class="fig xbox font-sm" id="liv70257-fig-0001"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d736/12320571/63d3e27ad851/LIV-45-0-g004.jpg" loading="lazy" id="jats-graphic-1" height="462" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/liv70257-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Flow chart of the study.</p></figcaption></figure></section><section id="liv70257-sec-0012"><h3 class="pmc_sec_title">2.2. Randomization</h3>
<p>Randomization was stratified according to center with a block size of 10 opaque envelopes and a random 1:1 allocation. Each local pharmacy department was responsible for the randomization and preparation of the study drug vials. Patients, medical and nursing staff, relatives, investigators, and members of the monitoring board remained unaware of study group assignments throughout the whole study period.</p></section><section id="liv70257-sec-0013"><h3 class="pmc_sec_title">2.3. Study Drug</h3>
<p>Pharmacy department of the participating hospitals prepared an infusion of 50 mL of saline serum containing 200 mg of hydrocortisone (HCS group) or 50 mL of saline (placebo group). Both solutions were identical and delivered daily to the ICU. Before starting the continuous infusion at a rate of 2 mL/h, all patients received an i.v. bolus of 50 mL of saline serum (placebo group) or 50 mL of saline containing 100 mg HCS. The study drug was initiated within 24 h after the start of norepinephrine (Figure <a href="#liv70257-supitem-0001" class="usa-link">S1</a>). Initial rate of the study drug was maintained until the start of Day 4 and at that point gradually discontinued [reduction of 0.5 mL/h per day (50 mg HCS per day)] when: (1) patients did not require vasoactive drugs anymore to maintain MAP &gt; 60 mmHg or &gt; 65 mmHg if signs of hypoperfusion or (2) in any case after a 7‐day treatment period (see Figures <a href="#liv70257-supitem-0001" class="usa-link">S2</a> and <a href="#liv70257-supitem-0001" class="usa-link">S3</a> for details regarding study overview and study drug tapering flow chart). Study protocol is available in the Data <a href="#liv70257-supitem-0002" class="usa-link">S2</a>.</p></section><section id="liv70257-sec-0014"><h3 class="pmc_sec_title">2.4. Definitions and Clinical and Laboratory Data Collection</h3>
<p>Definitions of cirrhosis, hypotension/shock, sepsis, different bacterial and fungal infections, adequate fluid resuscitation, refractory shock, shock relapse, new shock, ACLF, and appropriateness of empirical antibiotic therapy as well as clinical and laboratory data collected throughout the study are shown in the Data <a href="#liv70257-supitem-0001" class="usa-link">S1</a>.</p></section><section id="liv70257-sec-0015"><h3 class="pmc_sec_title">2.5. Endpoints</h3>
<p>The primary endpoint was 28‐day all‐cause mortality analysed from the day of randomisation. Secondary endpoints were ICU, hospital and 90‐day mortality, rate and time to shock reversal, reversal of organ failures, and ICU and hospital length of stay.</p>
<p>Adverse events were recorded as safety assessment, particularly shock relapse, new shock, new infections (bacterial, CMV or fungal episodes), hypo‐ and hyperglycaemia, and GI bleeding.</p></section><section id="liv70257-sec-0016"><h3 class="pmc_sec_title">2.6. Sample Size Estimation and Statistical Analysis</h3>
<p>We estimated a 28‐day probability of survival of 35% in the placebo group and of 50% in the HCS group [<a href="#liv70257-bib-0011" class="usa-link" aria-describedby="liv70257-bib-0011">11</a>]. Considering 5% wrong inclusions, 178 patients had to be included in each arm to detect a significant difference in 28‐day mortality (α error: 5%, β error: 20%; two‐tailed test). All analyses were performed on an intention‐to‐treat basis. Variables are summarised as frequencies and percentages or median and IQR, as appropriate. Continuous variables were compared with Kruskal‐Wallis' test. Categorical variables were compared with Chi‐square or Fisher's exact test. Time to event analyses were assessed by estimating the cumulative incidence function (CIF) and compared with the Grey's test. Predictors for 28‐day mortality were evaluated by fitting Cox proportional hazard regression models using backwards stepwise procedures. <em>p</em> &lt; 0.05 was considered statistically significant. All statistical analyses were performed using R Software v4.1.0/SAS v9.4.</p></section></section><section id="liv70257-sec-0017"><h2 class="pmc_sec_title">3. Results</h2>
<section id="liv70257-sec-0018"><h3 class="pmc_sec_title">3.1. Patients</h3>
<p>Three hundred eighteen patients with cirrhosis and sepsis requiring vasopressors were screened. After exclusion of 225, 93 were randomly allocated into the study. Ten patients (4 in the placebo and 6 in the HCS group) did not fulfil inclusion criteria (<em>n</em> = 2) or had some exclusion criteria (<em>n</em> = 8), resulting in 83 patients included in the final modified intention to treat analysis (43 in placebo and 40 in HCS arm; Figure <a href="#liv70257-fig-0001" class="usa-link">1</a>). Patients assigned to each treatment arm were balanced among hospitals. All patients received the study medication according to the protocol. One patient in the placebo group received HCS after the study period due to persistent shock. The trial steering committee decided to terminate the study early due to slow inclusion.</p></section><section id="liv70257-sec-0019"><h3 class="pmc_sec_title">3.2. Baseline Characteristics</h3>
<section id="liv70257-sec-0020"><h4 class="pmc_sec_title">3.2.1. Patients' Characteristics and Organ Support</h4>
<p>Baseline clinical characteristics including biochemical tests, especially total and free cortisol, MELD, MELD‐Na, Child‐Pugh, SOFA, and CLIF‐C OF scores were comparable between groups except for total serum bilirubin and albumin levels. Results of the Synacthen test are not reported since they were not available in most of the patients included in the Barcelona cohort due to technical reasons. Most patients had ACLF at inclusion with similar distribution of ACLF grades between groups (Table <a href="#liv70257-tbl-0001" class="usa-link">1</a>).</p>
<section class="tw xbox font-sm" id="liv70257-tbl-0001"><h5 class="obj_head">TABLE 1.</h5>
<div class="caption p"><p>Baseline clinical and analytical characteristics, severity and organ support in the hydrocortisone and placebo groups.<a href="#liv70257-note-0004" class="usa-link">
<sup>a</sup>
</a>
</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Variable</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">All (<em>n</em> = 83)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Hydrocortisone (<em>n</em> = 40)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Placebo (<em>n</em> = 43)</th>
</tr></thead>
<tbody valign="top">
<tr><td align="left" colspan="4" valign="top" rowspan="1">Demographics</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Age</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 62 (55.5, 67.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 63 (57.5, 67.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 62 (52.5, 68)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Sex (female)</td>
<td align="center" valign="top" rowspan="1" colspan="1">29/83 (34.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17/40 (42.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">12/43 (27.9%)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Aetiology of cirrhosis</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Alcohol</td>
<td align="center" valign="top" rowspan="1" colspan="1">64/83 (77.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">28/40 (70%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">36/43 (83.7%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Active alcoholism</td>
<td align="center" valign="top" rowspan="1" colspan="1">34/83 (41%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16/40 (40%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">18/43 (41.9%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">NAFLD</td>
<td align="center" valign="top" rowspan="1" colspan="1">10/83 (12%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4/40 (10%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6/43 (14%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hepatitis C</td>
<td align="center" valign="top" rowspan="1" colspan="1">12/83 (14.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8/40 (20%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4/43 (9.3%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Other</td>
<td align="center" valign="top" rowspan="1" colspan="1">10/83 (12%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7/40 (17.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/43 (7%)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Comorbidities</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cardiovascular disease</td>
<td align="center" valign="top" rowspan="1" colspan="1">9/83 (10.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6/40 (15%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/43 (7%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Diabetes mellitus</td>
<td align="center" valign="top" rowspan="1" colspan="1">25/83 (30.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">12/40 (30%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">13/43 (30.2%)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Clinical decompensations</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Ascites</td>
<td align="center" valign="top" rowspan="1" colspan="1">43/83 (51.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">19/40 (47.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">24/43 (55.8%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Gastrointestinal bleeding</td>
<td align="center" valign="top" rowspan="1" colspan="1">10/83 (12%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4/40 (10%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6/43 (14%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hepatic encephalopathy</td>
<td align="center" valign="top" rowspan="1" colspan="1">34/83 (41%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15/40 (37.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">19/43 (44.2%)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Physical examination/vital signs</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">BMI</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 26.6 (23.4, 29.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 27.9 (23.6, 30.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 26 (23.4, 28.5)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Mean arterial pressure (mmHg)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 72 (68, 76)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 72.5 (68, 76)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 71 (68, 75)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Heart rate (bpm)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 87 (74, 104)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 86 (75, 104)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 90 (73, 103)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Respiratory rate (bpm)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(82) 18 (15, 22)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 18 (14, 20)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(42) 18 (15.2, 23)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">SpO2/FiO2 ratio</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 333 (235, 357)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 323 (235, 357)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 333 (235, 420)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">PaO2/FiO2 ratio</td>
<td align="center" valign="top" rowspan="1" colspan="1">(67) 277 (188, 356)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(34) 280 (178, 357)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(33) 270 (195, 338)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Standard laboratory measures</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Haemoglobin (g/dL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(82) 8.6 (7.8, 10)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(39) 8.6 (7.7, 10.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 8.6 (8, 9.6)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Leucocytes (×10<sup>9</sup> cells/L)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(82) 11.6 (8.2, 17)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(39) 10.8 (7.2, 16.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 11.8 (9.8, 17.2)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Neutrophils (×10<sup>9</sup> cells/L)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(78) 8.8 (5.2, 13.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(37) 8.6 (5, 12)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(41) 9.2 (5.3, 14)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Platelets (×10<sup>3</sup> cells/L)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 96 (72, 136.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 92.5 (72, 124.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 101 (72, 140.5)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Glucose (mg/dL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(80) 165.5 (127, 232.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 167 (129.8, 227)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 165.5 (125, 242)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">C‐reactive protein (mg/L)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 66.7 (30.4, 109.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 54.7 (23.8, 95.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 79.5 (36.5, 112.9)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Procalcitonin (ng/mL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(54) 1.9 (0.7, 5.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(27) 1.9 (0.6, 6.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(27) 1.9 (1, 4.4)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Creatinine (mg/dL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 1.6 (1.1, 2.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 1.5 (1.1, 2.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 1.9 (1.2, 2.7)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Sodium (mEq/L)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 133 (130, 138.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 132.5 (130, 139)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 133.7 (129, 138.1)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">pH</td>
<td align="center" valign="top" rowspan="1" colspan="1">(67) 7.4 (7.34, 7.44)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(34) 7.42 (7.35, 7.46)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(33) 7.39 (7.32, 7.42)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">AST (U/L)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(82) 57.5 (38.2, 102.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 55 (37.8, 90.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(42) 59 (39.5, 102.5)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ALT (U/L)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 27 (18, 48)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 25.5 (17.8, 38.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 29 (19, 52.5)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Total bilirubin (mg/dL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 4.8 (1.9, 9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 5.2 (2.4, 10.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 3.1 (1.5, 6.2)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Albumin (g/dL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(81) 2.9 (2.5, 3.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(39) 3 (2.6, 3.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(42) 2.7 (2.4, 3.3)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">INR</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 1.9 (1.6, 2.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 1.9 (1.7, 2.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 1.9 (1.5, 2.5)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Lactate (mg/dL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 19.1 (15.2, 30.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 22.4 (15.6, 30)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 19 (14.5, 27.5)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Additional measures</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">HDL‐Cholesterol (mg/dL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(77) 17 (6, 21)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(38) 15 (5.2, 20)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(39) 17 (7, 21.5)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">LDL‐Cholesterol (mg/dL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(60) 43 (31.5, 64.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(27) 41 (23.5, 65.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(33) 43 (33, 64)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ACTH (pg/mL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(82) 8.8 (5.9, 15.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 7 (5.2, 13.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(42) 10.4 (6.8, 19.1)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">CBG (μg/mL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(82) 19.8 (14.7, 29.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 17.6 (14.8, 27.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(42) 24.4 (14.9, 31.7)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cortisol (μg/dL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(82) 15.8 (9.9, 25.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 14.1 (9.6, 27.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(42) 16.6 (10.8, 23.6)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Free cortisol (μg/dL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(82) 2.2 (1, 5.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 1.8 (1, 4.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(42) 2.6 (1.1, 5)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Organ support</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Norepinephrine dose at inclusion</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 0.2 (0.1, 0.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 0.2 (0.1, 0.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 0.1 (0.1, 0.3)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hours from start of vasopressor to initiation of study drug</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 16 (11.5, 22)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 15 (11, 19.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 18 (12.5, 22.5)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Refractory shock</td>
<td align="center" valign="top" rowspan="1" colspan="1">12/83 (14.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/40 (7.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9/43 (20.9%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Mechanical ventilation</td>
<td align="center" valign="top" rowspan="1" colspan="1">38/83 (45.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17/40 (42.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">21/43 (48.8%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Renal replacement therapy</td>
<td align="center" valign="top" rowspan="1" colspan="1">12/83 (14.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6/40 (15%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6/43 (14%)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Organ failures and ACLF</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Circulatory failure</td>
<td align="center" valign="top" rowspan="1" colspan="1">83/83 (100%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">40/40 (100%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">43/43 (100%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Renal failure</td>
<td align="center" valign="top" rowspan="1" colspan="1">38/83 (45.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16/40 (40%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">22/43 (51.2%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Respiratory failure</td>
<td align="center" valign="top" rowspan="1" colspan="1">28/83 (33.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15/40 (37.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">13/43 (30.2%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Liver failure</td>
<td align="center" valign="top" rowspan="1" colspan="1">16/83 (19.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10/40 (25%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6/43 (14%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Coagulation failure</td>
<td align="center" valign="top" rowspan="1" colspan="1">22/83 (26.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11/40 (27.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11/43 (25.6%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cerebral failure</td>
<td align="center" valign="top" rowspan="1" colspan="1">20/83 (24.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11/40 (27.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9/43 (20.9%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ACLF</td>
<td align="center" valign="top" rowspan="1" colspan="1">67/83 (80.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">31/40 (77.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">36/43 (83.7%)</td>
</tr>
<tr><td align="left" style="padding-left:10%" colspan="4" valign="top" rowspan="1">ACLF Grade</td></tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">6/83 (7.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/40 (7.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/43 (7%)</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">23/83 (27.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9/40 (22.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">14/43 (32.6%)</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">3a</td>
<td align="center" valign="top" rowspan="1" colspan="1">21/83 (25.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9/40 (22.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">12/43 (27.9%)</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">3b (4–6 OF)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17/83 (20.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10/40 (25%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7/43 (16.3%)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Scores</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">MELD score</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 26 (19, 32)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 28.5 (19, 34)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 25 (18, 31)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">MELD‐Na score</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 29 (24, 33)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 30 (23, 35)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 27 (24, 32)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Child‐Pugh score</td>
<td align="center" valign="top" rowspan="1" colspan="1">(81) 10 (8, 12)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(39) 10 (8, 12)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(42) 10 (8, 11)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">SOFA score</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 12 (9, 14)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 12 (9.8, 14)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 12 (9, 14)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">CLIF‐C OF score</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 12 (9, 13)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 12 (9, 13.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 11 (10, 13)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/liv70257-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="liv70257-note-0003"><p>Abbreviations: ACLF, acute‐on‐chronic liver failure; ACTH, Adrenocorticotropic hormone; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; CBG, cortisol binding globulin; CLIF‐C OF, chronic liver failure‐organ failure score; HDL. high‐density lipoprotein; INR, international normalised ratio; LDL, low‐density lipoprotein; MELD, Model for End‐Stage Liver Disease; NAFLD, non‐alcoholic fatty liver disease; SOFA, Sequential Organ Failure Assessment.</p></div>
<div class="fn" id="liv70257-note-0004">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Data are presented as number (percentage) for categorical variables and median (IQR) for continuous variables. For continuous variables, the number of included patients is mentioned between brackets.</p>
</div>
</div></section><p>There was no difference between groups regarding MAP, heart rate, serum lactate levels, time elapsed between the start of vasopressor and initiation of study drug [15 (11–19.5; IQR) vs. 18 h (12.5–22.5; IQR)], and norepinephrine dose at inclusion [0.2 μg/kg/min (0.1–0.3; IQR) vs. 0.1 μg/kg/min (0.1–0.3; IQR)]. Prevalence of refractory shock (norepinephrine dose [<a href="#liv70257-bib-0003" class="usa-link" aria-describedby="liv70257-bib-0003">3</a>] 0.5 μg/kg/min) was also not statistically different between groups. Similar baseline requirements of mechanical ventilation (42.5% vs. 48.8%) and renal replacement therapy (RRT) (15% vs. 14%) were observed between groups (Table <a href="#liv70257-tbl-0001" class="usa-link">1</a>).</p></section><section id="liv70257-sec-0021"><h4 class="pmc_sec_title">3.2.2. Baseline Infections</h4>
<p>Table <a href="#liv70257-tbl-0002" class="usa-link">2</a> shows the clinical and microbiological characteristics of baseline infections in both groups. There were 92 baseline infections, 42 and 50 in the HCS and placebo groups, respectively. Pneumonia was the most common infection (20.7%), followed by urinary tract infections and spontaneous bacterial peritonitis. Fifty‐one infections were culture positive. Origin, type, and microbiological characteristics of infections were similar between groups. Pathogens isolated in baseline infections are shown in the Data <a href="#liv70257-supitem-0001" class="usa-link">S1</a> and Table <a href="#liv70257-supitem-0001" class="usa-link">S1</a>. Prevalence of multidrug‐resistant (MDR) infections at inclusion did not differ between groups.</p>
<section class="tw xbox font-sm" id="liv70257-tbl-0002"><h5 class="obj_head">TABLE 2.</h5>
<div class="caption p"><p>Clinical and microbiological characteristics of baseline infections in the hydrocortisone and placebo groups.<a href="#liv70257-note-0006" class="usa-link">
<sup>a</sup>
</a>
</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Variable</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">All (<em>n</em> = 83)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Hydrocortisone (<em>n</em> = 40)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Placebo (<em>n</em> = 43)</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Number of infections</td>
<td align="center" valign="top" rowspan="1" colspan="1">92</td>
<td align="center" valign="top" rowspan="1" colspan="1">42</td>
<td align="center" valign="top" rowspan="1" colspan="1">50</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Patients with 2 or more infections</td>
<td align="center" valign="top" rowspan="1" colspan="1">8/83 (9.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2/40 (5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6/43 (14%)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Infections with 2 or more isolated bacteria</td>
<td align="center" valign="top" rowspan="1" colspan="1">12/92 (13%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6/42 (14.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6/50 (12%)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Type of infection—no. (%)</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Spontaneous bacterial peritonitis</td>
<td align="center" valign="top" rowspan="1" colspan="1">9/83 (10.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5/40 (12.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4/43 (9.3%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Urinary tract infection</td>
<td align="center" valign="top" rowspan="1" colspan="1">12/83 (14.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5/40 (12.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7/43 (16.3%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Pneumonia</td>
<td align="center" valign="top" rowspan="1" colspan="1">19/83 (22.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10/40 (25.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9/43 (20.9%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Skin/soft tissue infection</td>
<td align="center" valign="top" rowspan="1" colspan="1">7/83 (8.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4/40 (10.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/43 (7.0%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Spontaneous bacteremia</td>
<td align="center" valign="top" rowspan="1" colspan="1">8/83 (9.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2/40 (5.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6/43 (14.0%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Unidentified source of infection</td>
<td align="center" valign="top" rowspan="1" colspan="1">8/83 (9.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4/40 (10.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4/43 (9.3%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Others<a href="#liv70257-note-0007" class="usa-link">
<sup>b</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">28/83 (33.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">12/40 (30.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16/43 (37.2%)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Site of acquisition—no. (%)</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Community acquired</td>
<td align="center" valign="top" rowspan="1" colspan="1">33/83 (39.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16/40 (40.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17/43 (39.5%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Healthcare associated</td>
<td align="center" valign="top" rowspan="1" colspan="1">22/83 (26.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8/40 (20.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">14/43 (32.6%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hospital acquired</td>
<td align="center" valign="top" rowspan="1" colspan="1">30/83 (36.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16/40 (40.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">14/43 (32.6%)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Microbiological data—no. (%)</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Culture‐positive infections</td>
<td align="center" valign="top" rowspan="1" colspan="1">47/83 (56.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">20/40 (50%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">27/43 (62.8%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Infections by Gram‐positive cocci</td>
<td align="center" valign="top" rowspan="1" colspan="1">15/83 (18.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6/40 (15.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9/43 (20.9%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Infections by Gram‐negative bacilli</td>
<td align="center" valign="top" rowspan="1" colspan="1">20/83 (24.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7/40 (17.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">13/43 (30.2%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Infections by Gram‐positive cocci and Gram‐negative bacilli</td>
<td align="center" valign="top" rowspan="1" colspan="1">5/83 (6.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/40 (7.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2/43 (4.7%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Infections by Gram‐positive cocci and Gram‐negative bacilli and anaerobic bacteria</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/83 (1.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/40 (2.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/43 (0%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Infections by yeast</td>
<td align="center" valign="top" rowspan="1" colspan="1">4/83 (4.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/40 (2.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/43 (7.0%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Infections by anaerobic bacteria</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/83 (3.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2/40 (5.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/43 (2.3%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Other infections<a href="#liv70257-note-0008" class="usa-link">
<sup>c</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/83 (1.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/40 (0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/43 (2.3%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">MDR bacterial infections</td>
<td align="center" valign="top" rowspan="1" colspan="1">15/83 (18.1%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6/40 (15.0%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9/43 (20.9%)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/liv70257-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="liv70257-note-0005"><p>Abbreviation: MDR, multidrug‐resistant.</p></div>
<div class="fn" id="liv70257-note-0006">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Data are presented as numbers (percentage) for categorical variables.</p>
</div>
<div class="fn" id="liv70257-note-0007">
<sup>
<sup>b</sup>
</sup><p class="display-inline">Secondary peritonitis (HCS = 6, placebo = 6), severe acute pancreatitis (HCS = 1, placebo = 1), spontaneous empyema (HCS = 1, placebo = 1), pseudomembranous colitis (HCS = 2, placebo = 1), candidemia (HCS = 1, placebo = 3), catheter‐related infection bacteremia (placebo = 1), cholecystitis (placebo = 1), secondary bacteremia (HCS = 1), other gastrointestinal infection (placebo = 1), infected splenic infarct (placebo = 1), aortic valve endocarditis (placebo = 1).</p>
</div>
<div class="fn" id="liv70257-note-0008">
<sup>
<sup>c</sup>
</sup><p class="display-inline">Infection by 
<em>Aeromonas veronii</em>
.</p>
</div>
</div></section></section></section><section id="liv70257-sec-0022"><h3 class="pmc_sec_title">3.3. 28‐Day Mortality and Secondary Outcomes</h3>
<p>Table <a href="#liv70257-tbl-0003" class="usa-link">3</a> shows the clinical evolution of patients during the study period. At 28 days, 14 of 40 patients receiving HCS had died, compared to 17 of 43 assigned to receive placebo (35% vs. 39.5%; <em>p</em> = 0.84). CIF of survival at 28 days was also comparable between groups (Figure <a href="#liv70257-fig-0002" class="usa-link">2A</a>). ICU, hospital, and 90‐day mortality also did not differ between groups. ACLF (65.2%) and refractory septic shock (47.6%) were the main causes of death in HCS and placebo groups, respectively. No differences in 28‐day mortality were also observed when patients were grouped according to their clinical severity (grade of ACLF, MELD, doses of vasopressors), Table <a href="#liv70257-supitem-0001" class="usa-link">S2</a>.</p>
<section class="tw xbox font-sm" id="liv70257-tbl-0003"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Clinical outcome and mortality in the hydrocortisone and placebo groups.<a href="#liv70257-note-0010" class="usa-link">
<sup>a</sup>
</a>
</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Variable</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">All (<em>n</em> = 83)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Hydrocortisone (<em>n</em> = 40)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Placebo (<em>n</em> = 43)</th>
</tr></thead>
<tbody valign="top">
<tr><td align="left" colspan="4" valign="top" rowspan="1">Study drug administration and vasopressor dose</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Days of study drug administration</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 8 (8, 10)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 8 (8, 8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 8 (7.5, 11)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Maximum dose of norepinephrine</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 0.2 (0.1, 0.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 0.2 (0.1, 0.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 0.2 (0.1, 0.5)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Median dose of norepinephrine</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 0.1 (0, 0.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 0.1 (0, 0.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 0.1 (0, 0.2)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Details on antibiotic treatments</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Antibiotic duration (days)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(92) 10.5 (8, 14)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(42) 9.5 (7, 14)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(50) 11 (8, 14)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Adequate empiric antibiotic treatment</td>
<td align="center" valign="top" rowspan="1" colspan="1">62/83 (74.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">33/40 (82.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">29/43 (67.4%)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Evolution of baseline infection and shock</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Shock resolution</td>
<td align="center" valign="top" rowspan="1" colspan="1">65/83 (78.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">34/40 (85%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">31/43 (72.1%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Days to shock resolution</td>
<td align="center" valign="top" rowspan="1" colspan="1">(65) 3 (2, 6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(34) 3 (2.2, 4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 4 (2, 7.5)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Shock relapse</td>
<td align="center" valign="top" rowspan="1" colspan="1">4/83 (4.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2/40 (5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2/43 (4.7%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Infection resolution</td>
<td align="center" valign="top" rowspan="1" colspan="1">58/83 (69.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">31/40 (77.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">27/43 (62.8%)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Adverse events</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Any new organ failure</td>
<td align="center" valign="top" rowspan="1" colspan="1">36/83 (43.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">19/40 (47.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17/43 (39.5%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Gastrointestinal bleeding</td>
<td align="center" valign="top" rowspan="1" colspan="1">6/83 (7.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4/40 (10%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2/43 (4.7%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hyperglycemia</td>
<td align="center" valign="top" rowspan="1" colspan="1">51/81 (63%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">33/40 (82.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">18/41 (43.9%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hypoglycemia</td>
<td align="center" valign="top" rowspan="1" colspan="1">8/81 (9.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7/40 (17.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/41 (2.4%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">New bacterial or fungal infections</td>
<td align="center" valign="top" rowspan="1" colspan="1">32/83 (38.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15/40 (37.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17/43 (39.5%)</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Bacterial infections</td>
<td align="center" valign="top" rowspan="1" colspan="1">29/83 (34.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">13/40 (32.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16/43 (37.2%)</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">MDR bacterial infections</td>
<td align="center" valign="top" rowspan="1" colspan="1">12/72 (16.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7/35 (20%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5/37 (13.5%)</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Fungal infections</td>
<td align="center" valign="top" rowspan="1" colspan="1">4/83 (4.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/40 (7.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/43 (2.3%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">New shock after resolution of baseline shock</td>
<td align="center" valign="top" rowspan="1" colspan="1">8/83 (9.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/40 (7.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">5/43 (11.6%)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Organ support requirements</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Days free of vasopressors</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 6 (4, 11.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 6 (4.8, 12)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 5 (0.5, 11)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Days free of mechanical ventilation</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 7 (4.5, 14)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 7 (3.5, 14)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 7 (5.5, 13.5)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Days free of renal replacement therapy</td>
<td align="center" valign="top" rowspan="1" colspan="1">(83) 10 (7, 14)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 9.5 (7, 14)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(43) 11 (7, 14)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Length of stay in days (time limit of 90 days)</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">In ICU for survivors</td>
<td align="center" valign="top" rowspan="1" colspan="1">(55) 7 (4, 10)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(27) 5 (4, 7.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(28) 7 (5, 11)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">In hospital for survivors</td>
<td align="center" valign="top" rowspan="1" colspan="1">(40) 25 (16, 36.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(17) 23 (13, 36)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(23) 26 (18.5, 34)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Mortality</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ICU mortality</td>
<td align="center" valign="top" rowspan="1" colspan="1">28/83 (33.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">13/40 (32.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15/43 (34.9%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hospital mortality</td>
<td align="center" valign="top" rowspan="1" colspan="1">39/83 (47%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">20/40 (50%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">19/43 (44.2%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">28‐day mortality</td>
<td align="center" valign="top" rowspan="1" colspan="1">31/83 (37.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">14/40 (35%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17/43 (39.5%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">90‐day mortality</td>
<td align="center" valign="top" rowspan="1" colspan="1">44/83 (53%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">23/40 (57.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">21/43 (48.8%)</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Main cause of death</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ACLF</td>
<td align="center" valign="top" rowspan="1" colspan="1">23/44 (52.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15/23 (65.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">8/21 (38.1%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Refractory septic shock</td>
<td align="center" valign="top" rowspan="1" colspan="1">12/44 (27.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2/23 (8.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10/21 (47.6%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hypovolemic shock</td>
<td align="center" valign="top" rowspan="1" colspan="1">2/44 (4.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/23 (4.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/21 (4.8%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cerebral haemorrhage</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/44 (2.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/23 (4.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/21 (0%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ARDS</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/44 (2.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/23 (4.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0/21 (0%)</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Other<a href="#liv70257-note-0011" class="usa-link">
<sup>b</sup>
</a>
</td>
<td align="center" valign="top" rowspan="1" colspan="1">5/44 (11.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/23 (13%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2/21 (9.5%)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/liv70257-tbl-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="liv70257-note-0009"><p>Abbreviations: ACLF, acute‐on‐chronic liver failure; ARDS, acute respiratory distress syndrome; MDR, multidrug‐resistant.</p></div>
<div class="fn" id="liv70257-note-0010">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Data are presented as number (percentage) for categorical variables.</p>
</div>
<div class="fn" id="liv70257-note-0011">
<sup>
<sup>b</sup>
</sup><p class="display-inline">Other main causes of death: unknown (<em>n</em> = 4), heart failure (<em>n</em> = 1).</p>
</div>
</div></section><figure class="fig xbox font-sm" id="liv70257-fig-0002"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d736/12320571/4a4f2f703b39/LIV-45-0-g003.jpg" loading="lazy" id="jats-graphic-3" height="911" width="664" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/liv70257-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Cumulative incidence function of 28‐day mortality (panel A) and shock resolution (panel B) in patients receiving HCS (red line) or placebo (blue line).</p></figcaption></figure><p>No significant difference in median duration of study drug (8 days), median and maximum dose of norepinephrine, shock resolution rate (85% vs. 72.1% in the HCS and placebo groups, respectively), time to shock resolution [3 days (2.2–4; IQR) vs. 4 (2–7.5; IQR)] and shock relapse (5% vs. 4.7%) was observed between groups. A trend towards a faster resolution of shock was observed in patients receiving HCS in the CIF analysis (85% vs. 74.4%; <em>p</em> = 0.09; Figure <a href="#liv70257-fig-0002" class="usa-link">2B</a>). Figure <a href="#liv70257-fig-0003" class="usa-link">3</a> shows the evolution of MAP and norepinephrine requirements during the first 7 days. No significant differences were observed between groups at any time point. Median vasopressor‐, ventilator‐ and RRT‐free days and length of ICU and hospital stay were similar between groups.</p>
<figure class="fig xbox font-sm" id="liv70257-fig-0003"><h4 class="obj_head">FIGURE 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d736/12320571/12ae9c824e1c/LIV-45-0-g002.jpg" loading="lazy" id="jats-graphic-5" height="596" width="709" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/liv70257-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Mean arterial pressure and norepinephrine requirements in patients receiving HCS (red line) or placebo (blue line) during the first 7 days of therapy.</p></figcaption></figure><p>Initial infection resolved in 69.9% of patients, with no significant differences between groups (77.5% in HCS group vs. 62.8% in placebo group). The median duration of antibiotic treatment was also similar between groups (9.5 vs. 11 days). Importantly, most patients in both groups received adequate empirical antibiotic treatment (82.5% vs. 67.4%, respectively).</p></section><section id="liv70257-sec-0023"><h3 class="pmc_sec_title">3.4. Adverse Events</h3>
<p>Table <a href="#liv70257-tbl-0003" class="usa-link">3</a> shows the adverse events that occurred in both groups. During hospitalisation, 34.9% of patients developed new bacterial infections, with no significant differences between groups (32.5% in HCS and 37.2% in placebo). Tables <a href="#liv70257-supitem-0001" class="usa-link">S3</a> and <a href="#liv70257-supitem-0001" class="usa-link">S4</a> describe clinical and microbiological characteristics of these new infections. Notably, 16.7% of these superinfections were MDR (20% vs. 13.5% in the HCS and placebo groups, respectively). Invasive fungal infections were more frequently observed in patients receiving HCS, although differences were not statistically significant (7.5% and 2.3% in the HCS and placebo groups, respectively). No CMV infection was observed in the study. Figure <a href="#liv70257-fig-0004" class="usa-link">4</a> shows CIF for the development of superinfections, MDR infections, and fungal episodes between groups.</p>
<figure class="fig xbox font-sm" id="liv70257-fig-0004"><h4 class="obj_head">FIGURE 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d736/12320571/eeb93d6c707f/LIV-45-0-g001.jpg" loading="lazy" id="jats-graphic-7" height="1235" width="669" alt="FIGURE 4"></p>
<div class="p text-right font-secondary"><a href="figure/liv70257-fig-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Cumulative incidence function of new bacterial (panel A), new MDR bacterial (panel B), and new fungal infections (panel C) in patients receiving HCS (red line) or placebo (blue line).</p></figcaption></figure><p>Risk of GI bleeding, new shock episodes (7.5% vs. 11.6%), and new organ failures were comparable between groups. In contrast, HCS was associated with higher rates of hyperglycemia (82.5% vs. 43.9%; <em>p</em> &lt; 0.01) and hypoglycemia (17.5% vs. 2.4%; <em>p</em> = 0.03).</p></section><section id="liv70257-sec-0024"><h3 class="pmc_sec_title">3.5. Predictors of 28‐Day Mortality</h3>
<p>Table <a href="#liv70257-tbl-0004" class="usa-link">4</a> shows the baseline clinical and analytical characteristics in survivors and non‐survivors at 28 days. Non‐survivors at 28 days showed more advanced liver disease, with higher SOFA and CLIF‐C OF scores. All deceased patients had ACLF at inclusion. Severity of ACLF correlated with 28‐day mortality. Patients with ACLF‐3 at inclusion showed the highest mortality rate compared to ACLF‐2 and 1 (CIF: 59.4% vs. 30.4% vs. 20%, respectively; Figure <a href="#liv70257-supitem-0001" class="usa-link">S4A</a>). ACLF grade at day 7 after ICU admission was the best prognostic indicator. Patients with ACLF‐3 at day 7 showed an extremely high mortality compared to patients with ACLF‐2/1 or no ACLF (93.3% vs. 33.4% vs. 5.4%, respectively; Figure <a href="#liv70257-supitem-0001" class="usa-link">S4B</a>).</p>
<section class="tw xbox font-sm" id="liv70257-tbl-0004"><h4 class="obj_head">TABLE 4.</h4>
<div class="caption p"><p>Baseline clinical and analytical characteristics in survivors and non‐survivors.<a href="#liv70257-note-0013" class="usa-link">
<sup>a</sup>
</a>
</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Variable</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Survivors at 28 days (<em>n</em> = 52)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Non‐survivors at 28 days (<em>n</em> = 31)</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">
<em>p</em>
</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Study drug</td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
<td align="center" valign="top" rowspan="1" colspan="1"></td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hydrocortisone group</td>
<td align="center" valign="top" rowspan="1" colspan="1">26/52 (50%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">14/31 (45.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.84</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Duration of study drug (days)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(52) 8 (8, 9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 8 (7, 11)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.6</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hours from start of vasopressor to initiation of study drug</td>
<td align="center" valign="top" rowspan="1" colspan="1">(52) 16.5 (11.8, 22.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 16 (11, 21)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.91</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Demographics</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Age</td>
<td align="center" valign="top" rowspan="1" colspan="1">(52) 62 (54, 68.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 63 (56.5, 67)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.81</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Sex (female)</td>
<td align="center" valign="top" rowspan="1" colspan="1">19/52 (36.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">10/31 (32.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.87</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Clinical events</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Ascites</td>
<td align="center" valign="top" rowspan="1" colspan="1">22/52 (42.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">21/31 (67.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.04</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Gastrointestinal bleeding</td>
<td align="center" valign="top" rowspan="1" colspan="1">6/52 (11.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4/31 (12.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Hepatic encephalopathy</td>
<td align="center" valign="top" rowspan="1" colspan="1">13/52 (25%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">21/31 (67.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.01</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Standard laboratory measures</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Leucocytes (×10<sup>9</sup> cells/L)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(52) 11 (7.9, 18.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(30) 12 (9.8, 16.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.78</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">C‐reactive protein (mg/L)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(52) 80.3 (34.3, 114.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 45 (28.3, 95.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.17</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Procalcitonin (ng/mL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(33) 3.6 (0.6, 7.8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(21) 1.6 (1.2, 3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.36</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Creatinine (mg/dL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(52) 1.4 (1, 2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 2.5 (1.4, 3.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.01</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Sodium (mEq/L)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(52) 132 (130, 139)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 134 (131, 137.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.57</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">pH</td>
<td align="center" valign="top" rowspan="1" colspan="1">(41) 7.41 (7.32, 7.45)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(26) 7.4 (7.34, 7.44)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.67</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">AST (U/L)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(51) 50 (31, 92)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 69 (50, 136)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.06</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ALT (U/L)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(52) 26 (17.8, 46.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 29 (18, 51)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.59</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Total bilirubin (mg/dL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(52) 2.8 (1.3, 8)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 6 (4.4, 12.9)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.01</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Albumin (g/dL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(51) 2.9 (2.5, 3.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(30) 2.8 (2.5, 3.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.83</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">INR</td>
<td align="center" valign="top" rowspan="1" colspan="1">(52) 1.7 (1.6, 2.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 2.5 (1.9, 3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.01</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Lactate (mg/dL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(52) 18.7 (14.3, 24.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 21 (16.9, 37)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.18</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Additional measures</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">HDL‐Cholesterol (mg/dL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(48) 17.5 (6.8, 21)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(29) 11 (5, 20)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.29</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">LDL‐Cholesterol (mg/dL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(39) 41 (32, 65.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(21) 50 (21, 64)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.64</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ACTH (pg/mL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(51) 9 (6.3, 14.7)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 8.2 (5, 18.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.74</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">CBG (μg/mL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(51) 25.1 (16.1, 35)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 16.1 (12.5, 25.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.01</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cortisol (μg/dL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(51) 14.9 (9.1, 23.6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 15.9 (12.1, 28.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.38</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Free cortisol (μg/dL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(51) 1.5 (0.8, 3.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 3.3 (1.3, 5.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.05</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Organ support at inclusion</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Volume of intravenous fluid before inclusion (mL)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(48) 500 (500, 500)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(30) 500 (325, 500)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.19</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Albumin</td>
<td align="center" valign="top" rowspan="1" colspan="1">(35) 500 (500, 500)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(20) 450 (100, 500)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.07</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">Others</td>
<td align="center" valign="top" rowspan="1" colspan="1">(15) 500 (500, 999)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(11) 500 (500, 500)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.68</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Albumin dose before inclusion (g)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(35) 25 (25, 25)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(20) 25 (20, 25)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.29</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Mechanical ventilation</td>
<td align="center" valign="top" rowspan="1" colspan="1">22/52 (42.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">16/31 (51.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.55</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Renal replacement therapy</td>
<td align="center" valign="top" rowspan="1" colspan="1">3/52 (5.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9/31 (29%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Norepinephrine dose</td>
<td align="center" valign="top" rowspan="1" colspan="1">(52) 0.1 (0.1, 0.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 0.2 (0.1, 0.3)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.43</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Refractory shock</td>
<td align="center" valign="top" rowspan="1" colspan="1">6/52 (11.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6/31 (19.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.51</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Inadequacy of empirical antibiotic treatment</td>
<td align="center" valign="top" rowspan="1" colspan="1">4/52 (7.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">17/31 (54.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.01</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Organ failures and ACLF</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Renal failure</td>
<td align="center" valign="top" rowspan="1" colspan="1">16/52 (30.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">22/31 (71%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.01</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Respiratory failure</td>
<td align="center" valign="top" rowspan="1" colspan="1">16/52 (30.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">12/31 (38.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.62</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Liver failure</td>
<td align="center" valign="top" rowspan="1" colspan="1">7/52 (13.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">9/31 (29%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.15</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Coagulation failure</td>
<td align="center" valign="top" rowspan="1" colspan="1">7/52 (13.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">15/31 (48.4%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.01</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Cerebral failure</td>
<td align="center" valign="top" rowspan="1" colspan="1">7/52 (13.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">13/31 (41.9%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.01</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">ACLF</td>
<td align="center" valign="top" rowspan="1" colspan="1">36/52 (69.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">31/31 (100%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.01</td>
</tr>
<tr><td align="left" style="padding-left:10%" colspan="4" valign="top" rowspan="1">ACLF grade</td></tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">1</td>
<td align="center" valign="top" rowspan="1" colspan="1">5/52 (9.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1/31 (3.2%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.4</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">2</td>
<td align="center" valign="top" rowspan="1" colspan="1">16/52 (30.8%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7/31 (22.6%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.58</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">3a</td>
<td align="center" valign="top" rowspan="1" colspan="1">9/52 (17.3%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">12/31 (38.7%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.06</td>
</tr>
<tr>
<td align="left" style="padding-left:15%" valign="top" rowspan="1" colspan="1">3b (4–6 OF)</td>
<td align="center" valign="top" rowspan="1" colspan="1">6/52 (11.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">11/31 (35.5%)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.02</td>
</tr>
<tr><td align="left" colspan="4" valign="top" rowspan="1">Scores</td></tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">MELD score</td>
<td align="center" valign="top" rowspan="1" colspan="1">(52) 21 (17, 28.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 32 (27, 38.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.01</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">MELD‐Na score</td>
<td align="center" valign="top" rowspan="1" colspan="1">(52) 25 (21, 30.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 33 (31, 38.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.01</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">Child‐Pugh score</td>
<td align="center" valign="top" rowspan="1" colspan="1">(51) 9 (8, 10)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(30) 12 (11, 12)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.01</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">SOFA score</td>
<td align="center" valign="top" rowspan="1" colspan="1">(52) 11 (8, 12.2)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 14 (11, 15)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.01</td>
</tr>
<tr>
<td align="left" style="padding-left:10%" valign="top" rowspan="1" colspan="1">CLIF‐C OF score</td>
<td align="center" valign="top" rowspan="1" colspan="1">(52) 10 (9, 12)</td>
<td align="center" valign="top" rowspan="1" colspan="1">(31) 13 (12, 14.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">&lt; 0.01</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/liv70257-tbl-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="liv70257-note-0012"><p>Abbreviations: ACLF, acute‐on‐chronic liver failure; ACTH, adrenocorticotropic hormone; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; CBG, cortisol binding globulin; CLIF‐C OF, chronic liver failure‐organ failure score; HDL, high‐density lipoprotein; INR, international normalised ratio; LDL, low‐density lipoprotein; MELD, Model for End‐Stage Liver Disease; NAFLD, non‐alcoholic fatty liver disease; SOFA, Sequential Organ Failure Assessment.</p></div>
<div class="fn" id="liv70257-note-0013">
<sup>
<sup>a</sup>
</sup><p class="display-inline">Data are presented as numbers (percentage) for categorical variables and median (IQR) for continuous variables. For continuous variables, the number of included patients is mentioned between brackets.</p>
</div>
</div></section><p>Characteristics of baseline infections did not differ between survivors and non‐survivors (Table <a href="#liv70257-supitem-0001" class="usa-link">S5</a>). In contrast, the adequacy of initial empirical antibiotic treatment was significantly associated with outcome. Inadequate initial treatment was observed in 54.8% of non‐survivors compared to only 7.7% of survivors. Mortality of ACLF 2–3 subjects who initially received inappropriate antibiotics doubled that observed in patients treated with appropriate antibiotics (Figure <a href="#liv70257-supitem-0001" class="usa-link">S4C</a>). The impact of the adequacy of initial antibiotic strategies was also observed when only culture‐positive infections were analysed (Figure <a href="#liv70257-supitem-0001" class="usa-link">S5</a>).</p>
<p>Multivariable analysis identified inadequacy of empirical antibiotic treatment (HR = 6.52; 95% CI: 3.23–13.16) and ACLF grade (grade 3 vs. grade 1 HR = 5.72; 95% CI: 2.30–14.22; grade 3 vs. grade 2 HR = 3.29; 95% CI: 1.37–7.90) as the only independent predictors of 28‐day mortality. Variables entered in this model and an alternative prognostic model in which ACLF was replaced by different organ failures are described in the Data <a href="#liv70257-supitem-0001" class="usa-link">S1</a> and in Table <a href="#liv70257-supitem-0001" class="usa-link">S6</a>.</p></section></section><section id="liv70257-sec-0025"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>Prognosis of cirrhotic patients with septic shock is worse than that observed in the general population. Preexisting circulatory dysfunction, more severe systemic inflammation, and poor response to vasopressors increase the risk of refractory shock, organ failure, and mortality [<a href="#liv70257-bib-0022" class="usa-link" aria-describedby="liv70257-bib-0022">22</a>]. RAI, a frequent entity in cirrhotic patients with sepsis, impairs haemodynamic stability and systemic inflammation and contributes to the development of ACLF [<a href="#liv70257-bib-0017" class="usa-link" aria-describedby="liv70257-bib-0017">17</a>, <a href="#liv70257-bib-0022" class="usa-link" aria-describedby="liv70257-bib-0022">22</a>]. RAI is not only highly prevalent in cirrhosis, with poorer liver function correlating with higher incidence [<a href="#liv70257-bib-0023" class="usa-link" aria-describedby="liv70257-bib-0023">23</a>], but also associated with increased mortality [<a href="#liv70257-bib-0022" class="usa-link" aria-describedby="liv70257-bib-0022">22</a>]. Therefore, there is a pathophysiological rationale for expecting a beneficial effect of steroids in cirrhotic patients with septic shock.</p>
<p>Regretfully, in this randomised controlled trial evaluating HCS versus placebo in cirrhotic patients with septic shock requiring mainly low to moderate doses of vasopressors, we observed no significant difference in 28‐day mortality between treatment groups. Key secondary objectives including shock resolution, renal and respiratory support, and length of ICU stay were also not impacted by the study drug.</p>
<p>Data from retrospective studies and RCTs on the effect of HCS supplementation for septic shock in both general and cirrhotic populations showed a beneficial haemodynamic impact with faster vasopressor reduction and more shock reversal, especially in patients with RAI [<a href="#liv70257-bib-0003" class="usa-link" aria-describedby="liv70257-bib-0003">3</a>, <a href="#liv70257-bib-0004" class="usa-link" aria-describedby="liv70257-bib-0004">4</a>, <a href="#liv70257-bib-0005" class="usa-link" aria-describedby="liv70257-bib-0005">5</a>, <a href="#liv70257-bib-0011" class="usa-link" aria-describedby="liv70257-bib-0011">11</a>, <a href="#liv70257-bib-0013" class="usa-link" aria-describedby="liv70257-bib-0013">13</a>, <a href="#liv70257-bib-0022" class="usa-link" aria-describedby="liv70257-bib-0022">22</a>, <a href="#liv70257-bib-0024" class="usa-link" aria-describedby="liv70257-bib-0024">24</a>, <a href="#liv70257-bib-0025" class="usa-link" aria-describedby="liv70257-bib-0025">25</a>]. The effect on mortality, however, was unclear. Only one RCT has been published investigating the effect of HCS in 75 patients with cirrhosis and septic shock [<a href="#liv70257-bib-0024" class="usa-link" aria-describedby="liv70257-bib-0024">24</a>]. HCS increased shock reversal but did not affect short‐term mortality. A higher incidence of shock relapse after discontinuation of HCS and a higher number of adverse events were reported in the steroid group. A late initiation of the study drug (72 h from the onset of shock) and the inclusion of extremely ill patients could explain these negative results. In the current RCT, both potential confounders were avoided. HCS was started within the first 24 h of the onset of shock, and extremely ill patients (Child Pugh &gt; 13 and/or SOFA &gt; 16) were excluded. Consequently, the severity of our patients was substantially lower than that observed in the Arabi study in terms of vasopressor doses, mechanical ventilation (45.8% vs. 82.7%) and RRT (14.5% vs. 69.3%) requirements. 28‐day mortality was also markedly lower in our study, 37.3% vs. 78.6% in the Arabi study [<a href="#liv70257-bib-0024" class="usa-link" aria-describedby="liv70257-bib-0024">24</a>]. The mortality rate observed in our study was also lower than that estimated in our power calculation [<a href="#liv70257-bib-0011" class="usa-link" aria-describedby="liv70257-bib-0011">11</a>]. Earlier and aggressive ICU treatment, previously thought to be futile, probably resulted in better outcomes [<a href="#liv70257-bib-0026" class="usa-link" aria-describedby="liv70257-bib-0026">26</a>]. Indeed, the prognosis of patients with or without cirrhosis in ICU using propensity score matching is similar [<a href="#liv70257-bib-0027" class="usa-link" aria-describedby="liv70257-bib-0027">27</a>].</p>
<p>A possible explanation for the lack of positive effects of HCS in the current study could be the low baseline vasopressor requirements observed in most of the patients. Recent guidelines suggest the use of HCS in septic shock with norepinephrine dose ≥ 0.25 μg/kg/min for more than 4 h [<a href="#liv70257-bib-0021" class="usa-link" aria-describedby="liv70257-bib-0021">21</a>, <a href="#liv70257-bib-0028" class="usa-link" aria-describedby="liv70257-bib-0028">28</a>], a threshold that only a third of our patients reached (37.3%). Since RAI has been reported in a high proportion of patients with cirrhosis and sepsis even without shock, we decided to include patients with low vasopressor requirements considering their high risk of organ failure. The effect of HCS in patients with refractory shock could not be elucidated in this study due to the low number of subjects with high doses of vasopressors.</p>
<p>When comparing survivors and non‐survivors, we observed that norepinephrine dose at inclusion and mechanical ventilation were similar in both groups. However, non‐survivors presented more frequently with ascites, hepatic encephalopathy, coagulation, and renal failure and higher severity scores. ACLF was more frequent in deceased patients. This suggests that the severity of the underlying cirrhosis and renal impairment are the most important factors contributing to mortality (as opposed to circulatory and respiratory failure), factors which cannot be reversed or prevented with HCS treatment [<a href="#liv70257-bib-0029" class="usa-link" aria-describedby="liv70257-bib-0029">29</a>]. In that sense, ACLF was identified as an independent predictor of mortality and was also the major cause of death in patients receiving steroids. As such, early liver transplantation should be considered in patients with severe ACLF and septic shock, once infection is under control.</p>
<p>As expected, the use of inadequate empirical antibiotic strategies was identified as an independent predictor of mortality, especially in ACLF 3. This finding was reported in observational studies in patients with cirrhosis and septic shock [<a href="#liv70257-bib-0030" class="usa-link" aria-describedby="liv70257-bib-0030">30</a>]. Our results support, therefore, current guidelines on the use of broad‐spectrum antibiotics covering all potential pathogens in patients with septic shock. This recommendation is also applicable to community‐acquired episodes given the wide spread of antibiotic resistance in the community [<a href="#liv70257-bib-0021" class="usa-link" aria-describedby="liv70257-bib-0021">21</a>].</p>
<p>In contrast to our trial, other studies have reported a significant increase in steroid‐associated adverse events, such as shock relapse, new shock episodes, new infections and GI bleeding. In the current study, the incidence of bacterial superinfections, a feared complication in cirrhosis associated with worse outcome [<a href="#liv70257-bib-0031" class="usa-link" aria-describedby="liv70257-bib-0031">31</a>], was similar between treatment arms. New MDR bacterial and fungal infections were observed more frequently in patients receiving HCS, although differences were not statistically significant.</p>
<p>There were three main limitations of our study. First, the pre‐planned inclusion number and the calculated statistical power were not reached, indicating that our results should be interpreted with caution and considered inconclusive. Subsequent pre‐planned subgroup analyses could not be performed due to low numbers. Despite this weakness, this is the largest RCT conducted so far on HCS supplementation in cirrhotic patients with septic shock and was double‐blind. Second, we did not use cortisol levels to randomise the groups or to perform subgroup analyses, as the interpretation as well as the definition of RAI is still controversial, especially in cirrhosis. Additionally, guidelines do not advise basing the decision to initiate steroid treatment in septic shock patients on cortisol levels. Moreover, different measurement methods make comparison with other trials and usability in daily clinical practice difficult [<a href="#liv70257-bib-0032" class="usa-link" aria-describedby="liv70257-bib-0032">32</a>, <a href="#liv70257-bib-0033" class="usa-link" aria-describedby="liv70257-bib-0033">33</a>]. Third, the study was analysed on a modified intention‐to‐treat basis since 10 subjects were considered ineligible post‐randomisation. However, their inclusion in the ITT analysis could have biased the final results of the study.</p>
<p>Finally, several reasons explain the low recruitment rate that led to the early termination of the study. Significant budgetary constraints (no inclusion fee), highly demanding and complex investigation, and a limited network of centres with dedicated research staff complicated the conduct of this investigator‐initiated research.</p>
<p>In conclusion, supplemental HCS showed no impact on survival in patients with cirrhosis and septic shock requiring low to moderate doses of vasopressors. However, as the study was underpowered, the findings should be interpreted as inconclusive. Larger, adequately powered studies are needed to determine whether hydrocortisone confers a mortality benefit in this specific population. Severity of underlying liver disease, ACLF, and inadequate empirical antibiotic treatment played a more important prognostic role than circulatory failure in this population.</p></section><section id="liv70257-sec-0026"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>P.M., V.A., A.W. and J.F. designed the study, M.H.‐T., F.A., H.C., V.P., M.A. and J.A. participated in patient recruitment and data collection, P.M., M.H.‐T., J.M.D., J.W., G.H., H.C., L.L., D.T., M.L., J.Z., A.W. and J.F. participated in data analysis and interpretation. P.M., M.H.‐T., J.M.D., V.A., A.W., J.F. participated in the writing group. P.M., V.A., A.W. and J.F. were responsible for overall project execution.</p></section><section id="liv70257-sec-0028"><h2 class="pmc_sec_title">Ethics Statement</h2>
<p>The study was approved by local Ethical Committees (Leuven <a href="https://www.ncbi.nlm.nih.gov/protein/S55168" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">S55168</a>, Barcelona HCB/2014/0268, Plymouth 207 950).</p></section><section id="liv70257-sec-0029"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflicts of interest.</p></section><section id="sec26"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="liv70257-supitem-0001"><div class="caption p"><p>
<strong>Data S1</strong> liv70257‐sup‐0001‐DataS1.docx.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12320571/bin/LIV-45-0-s002.docx" data-ga-action="click_feat_suppl" class="usa-link">LIV-45-0-s002.docx</a><sup> (828.6KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="liv70257-supitem-0002"><div class="caption p"><p>
<strong>Data S2</strong> liv70257‐sup‐0002‐DataS2.pdf.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12320571/bin/LIV-45-0-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">LIV-45-0-s001.pdf</a><sup> (1.1MB, pdf) </sup>
</div></div></section></section><section id="liv70257-sec-0027" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>The authors have nothing to report.</p></section><section id="notes1"><p>

Meersseman P., Hernández‐Tejero M., Diaz J. M., et al., “Low‐Dose Hydrocortisone in Cirrhotic Patients With Septic Shock: A Double‐Blind Randomised Placebo‐Controlled Trial,” Liver International
45, no. 9 (2025): e70257, 10.1111/liv.70257.
</p>
<section id="liv70257-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="liv70257-note-0001"><p>
<strong>Funding:</strong> This work was supported by European Foundation for the Study of Chronic Liver Failure, EF CLIF, Barcelona, Spain.</p></div>
<div class="fn p" id="liv70257-note-0002"><p>Alexander Wilmer and Javier Fernandez contributed equally to this work.</p></div>
<div class="fn p" id="liv70257-note-1001"><p>
<strong>Handling Editor:</strong> Minneke J. Coenraad</p></div>
</div></section></section><section id="liv70257-sec-0031"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.</p></section><section id="liv70257-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="liv70257-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="liv70257-bib-0001">
<span class="label">1.</span><cite>
Annane D., Pastores S. M., Rochwerg B., et al., “Guidelines for the Diagnosis and Management of Critical Illness‐Related Corticosteroid Insufficiency (CIRCI) in Critically Ill Patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017,” Intensive Care Medicine
43 (2017): 1751–1763.
</cite> [<a href="https://doi.org/10.1007/s00134-017-4919-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28940011/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Intensive%20Care%20Medicine&amp;title=Guidelines%20for%20the%20Diagnosis%20and%20Management%20of%20Critical%20Illness%E2%80%90Related%20Corticosteroid%20Insufficiency%20(CIRCI)%20in%20Critically%20Ill%20Patients%20(Part%20I):%20Society%20of%20Critical%20Care%20Medicine%20(SCCM)%20and%20European%20Society%20of%20Intensive%20Care%20Medicine%20(ESICM)%202017&amp;author=D.%20Annane&amp;author=S.%20M.%20Pastores&amp;author=B.%20Rochwerg&amp;volume=43&amp;publication_year=2017&amp;pages=1751-1763&amp;pmid=28940011&amp;doi=10.1007/s00134-017-4919-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0002">
<span class="label">2.</span><cite>
Sprung C. L., Annane D., Keh D., et al., “Hydrocortisone Therapy for Patients With Septic Shock,” New England Journal of Medicine
358 (2008): 111–124.
</cite> [<a href="https://doi.org/10.1056/NEJMoa071366" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18184957/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Hydrocortisone%20Therapy%20for%20Patients%20With%20Septic%20Shock&amp;author=C.%20L.%20Sprung&amp;author=D.%20Annane&amp;author=D.%20Keh&amp;volume=358&amp;publication_year=2008&amp;pages=111-124&amp;pmid=18184957&amp;doi=10.1056/NEJMoa071366&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0003">
<span class="label">3.</span><cite>
Annane D., Sébille V., Charpentier C., et al., “Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic Shock,” Journal of the American Medical Association
288 (2002): 862–871.
</cite> [<a href="https://doi.org/10.1001/jama.288.7.862" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12186604/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20American%20Medical%20Association&amp;title=Effect%20of%20Treatment%20With%20Low%20Doses%20of%20Hydrocortisone%20and%20Fludrocortisone%20on%20Mortality%20in%20Patients%20With%20Septic%20Shock&amp;author=D.%20Annane&amp;author=V.%20S%C3%A9bille&amp;author=C.%20Charpentier&amp;volume=288&amp;publication_year=2002&amp;pages=862-871&amp;pmid=12186604&amp;doi=10.1001/jama.288.7.862&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0004">
<span class="label">4.</span><cite>
Venkatesh B., Finfer S., Cohen J., et al., “Adjunctive Glucocorticoid Therapy in Patients With Septic Shock,” New England Journal of Medicine
378 (2018): 797–808.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1705835" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29347874/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Adjunctive%20Glucocorticoid%20Therapy%20in%20Patients%20With%20Septic%20Shock&amp;author=B.%20Venkatesh&amp;author=S.%20Finfer&amp;author=J.%20Cohen&amp;volume=378&amp;publication_year=2018&amp;pages=797-808&amp;pmid=29347874&amp;doi=10.1056/NEJMoa1705835&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0005">
<span class="label">5.</span><cite>
Annane D., Renault A., Brun‐Buisson C., et al., “Hydrocortisone Plus Fludrocortisone for Adults With Septic Shock,” New England Journal of Medicine
378 (2018): 809–818.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1705716" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29490185/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Hydrocortisone%20Plus%20Fludrocortisone%20for%20Adults%20With%20Septic%20Shock&amp;author=D.%20Annane&amp;author=A.%20Renault&amp;author=C.%20Brun%E2%80%90Buisson&amp;volume=378&amp;publication_year=2018&amp;pages=809-818&amp;pmid=29490185&amp;doi=10.1056/NEJMoa1705716&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0006">
<span class="label">6.</span><cite>
Rygård S. L., Butler E., Granholm A., et al., “Low‐Dose Corticosteroids for Adult Patients With Septic Shock: A Systematic Review With Meta‐Analysis and Trial Sequential Analysis,” Intensive Care Medicine
44 (2018): 1003–1016.
</cite> [<a href="https://doi.org/10.1007/s00134-018-5197-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29761216/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Intensive%20Care%20Medicine&amp;title=Low%E2%80%90Dose%20Corticosteroids%20for%20Adult%20Patients%20With%20Septic%20Shock:%20A%20Systematic%20Review%20With%20Meta%E2%80%90Analysis%20and%20Trial%20Sequential%20Analysis&amp;author=S.%20L.%20Ryg%C3%A5rd&amp;author=E.%20Butler&amp;author=A.%20Granholm&amp;volume=44&amp;publication_year=2018&amp;pages=1003-1016&amp;pmid=29761216&amp;doi=10.1007/s00134-018-5197-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0007">
<span class="label">7.</span><cite>
Gibbison B., López‐López J. A., Higgins J. P. T., et al., “Corticosteroids in Septic Shock: A Systematic Review and Network Meta‐Analysis,” Critical Care
21 (2017): 1–8.
</cite> [<a href="https://doi.org/10.1186/s13054-017-1659-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5371269/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28351429/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Critical%20Care&amp;title=Corticosteroids%20in%20Septic%20Shock:%20A%20Systematic%20Review%20and%20Network%20Meta%E2%80%90Analysis&amp;author=B.%20Gibbison&amp;author=J.%20A.%20L%C3%B3pez%E2%80%90L%C3%B3pez&amp;author=J.%20P.%20T.%20Higgins&amp;volume=21&amp;publication_year=2017&amp;pages=1-8&amp;pmid=28351429&amp;doi=10.1186/s13054-017-1659-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0008">
<span class="label">8.</span><cite>
Van den Berghe G., Téblick A., Langouche L., et al., “The Hypothalamus‐Pituitary‐Adrenal Axis in Sepsis‐ and Hyperinflammation‐Induced Critical Illness: Gaps in Current Knowledge and Future Translational Research Directions,” eBioMedicine
84 (2022): 104284.
</cite> [<a href="https://doi.org/10.1016/j.ebiom.2022.104284" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9519475/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36162206/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=eBioMedicine&amp;title=The%20Hypothalamus%E2%80%90Pituitary%E2%80%90Adrenal%20Axis%20in%20Sepsis%E2%80%90%20and%20Hyperinflammation%E2%80%90Induced%20Critical%20Illness:%20Gaps%20in%20Current%20Knowledge%20and%20Future%20Translational%20Research%20Directions&amp;author=G.%20Van%20den%20Berghe&amp;author=A.%20T%C3%A9blick&amp;author=L.%20Langouche&amp;volume=84&amp;publication_year=2022&amp;pages=104284&amp;pmid=36162206&amp;doi=10.1016/j.ebiom.2022.104284&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0009">
<span class="label">9.</span><cite>
Boonen E., Vervenne H., Meersseman P., et al., “Reduced Cortisol Metabolism During Critical Illness,” New England Journal of Medicine
368 (2013): 1477–1488.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1214969" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4413428/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23506003/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=New%20England%20Journal%20of%20Medicine&amp;title=Reduced%20Cortisol%20Metabolism%20During%20Critical%20Illness&amp;author=E.%20Boonen&amp;author=H.%20Vervenne&amp;author=P.%20Meersseman&amp;volume=368&amp;publication_year=2013&amp;pages=1477-1488&amp;pmid=23506003&amp;doi=10.1056/NEJMoa1214969&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0010">
<span class="label">10.</span><cite>
Téblick A., Peeters B., Langouche L., and van den Berghe G., “Adrenal Function and Dysfunction in Critically Ill Patients,” Nature Reviews. Endocrinology
15 (2019): 417–427, 10.1038/s41574-019-0185-7.</cite> [<a href="https://doi.org/10.1038/s41574-019-0185-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30850749/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews.%20Endocrinology&amp;title=Adrenal%20Function%20and%20Dysfunction%20in%20Critically%20Ill%20Patients&amp;author=A.%20T%C3%A9blick&amp;author=B.%20Peeters&amp;author=L.%20Langouche&amp;author=G.%20van%20den%20Berghe&amp;volume=15&amp;publication_year=2019&amp;pages=417-427&amp;pmid=30850749&amp;doi=10.1038/s41574-019-0185-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0011">
<span class="label">11.</span><cite>
Fernández J., Escorsell A., Zabalza M., et al., “Adrenal Insufficiency in Patients With Cirrhosis and Septic Shock: Effect of Treatment With Hydrocortisone on Survival,” Hepatology
44 (2006): 1288–1295.
</cite> [<a href="https://doi.org/10.1002/hep.21352" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17058239/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Adrenal%20Insufficiency%20in%20Patients%20With%20Cirrhosis%20and%20Septic%20Shock:%20Effect%20of%20Treatment%20With%20Hydrocortisone%20on%20Survival&amp;author=J.%20Fern%C3%A1ndez&amp;author=A.%20Escorsell&amp;author=M.%20Zabalza&amp;volume=44&amp;publication_year=2006&amp;pages=1288-1295&amp;pmid=17058239&amp;doi=10.1002/hep.21352&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0012">
<span class="label">12.</span><cite>
Marik P. E., Gayowski T., and Starzl T. E., “The Hepatoadrenal Syndrome: A Common Yet Unrecognized Clinical Condition,” Critical Care Medicine
33 (2005): 1254–1259.
</cite> [<a href="https://doi.org/10.1097/01.ccm.0000164541.12106.57" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2989684/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15942340/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Critical%20Care%20Medicine&amp;title=The%20Hepatoadrenal%20Syndrome:%20A%20Common%20Yet%20Unrecognized%20Clinical%20Condition&amp;author=P.%20E.%20Marik&amp;author=T.%20Gayowski&amp;author=T.%20E.%20Starzl&amp;volume=33&amp;publication_year=2005&amp;pages=1254-1259&amp;pmid=15942340&amp;doi=10.1097/01.ccm.0000164541.12106.57&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0013">
<span class="label">13.</span><cite>
Harry R., Auzinger G., and Wendon J., “The Effects of Supraphysiological Doses of Corticosteroids in Hypotensive Liver Failure,” Liver International
23 (2003): 71–77.
</cite> [<a href="https://doi.org/10.1034/j.1600-0676.2003.00813.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12654129/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Liver%20International&amp;title=The%20Effects%20of%20Supraphysiological%20Doses%20of%20Corticosteroids%20in%20Hypotensive%20Liver%20Failure&amp;author=R.%20Harry&amp;author=G.%20Auzinger&amp;author=J.%20Wendon&amp;volume=23&amp;publication_year=2003&amp;pages=71-77&amp;pmid=12654129&amp;doi=10.1034/j.1600-0676.2003.00813.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0014">
<span class="label">14.</span><cite>
Fede G., Spadaro L., Tomaselli T., et al., “Adrenocortical Dysfunction in Liver Disease: A Systematic Review,” Hepatology
55 (2012): 1282–1291.
</cite> [<a href="https://doi.org/10.1002/hep.25573" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22234976/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Adrenocortical%20Dysfunction%20in%20Liver%20Disease:%20A%20Systematic%20Review&amp;author=G.%20Fede&amp;author=L.%20Spadaro&amp;author=T.%20Tomaselli&amp;volume=55&amp;publication_year=2012&amp;pages=1282-1291&amp;pmid=22234976&amp;doi=10.1002/hep.25573&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0015">
<span class="label">15.</span><cite>
Wentworth B. J., Henry Z. H., and Siragy H. M., “How I Approach It: Adrenal Insufficiency in Cirrhosis,” American Journal of Gastroenterology
117 (2022): 1889–1893.
</cite> [<a href="https://doi.org/10.14309/ajg.0000000000001939" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9722576/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35980083/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Gastroenterology&amp;title=How%20I%20Approach%20It:%20Adrenal%20Insufficiency%20in%20Cirrhosis&amp;author=B.%20J.%20Wentworth&amp;author=Z.%20H.%20Henry&amp;author=H.%20M.%20Siragy&amp;volume=117&amp;publication_year=2022&amp;pages=1889-1893&amp;pmid=35980083&amp;doi=10.14309/ajg.0000000000001939&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0016">
<span class="label">16.</span><cite>
Theiler‐Schwetz V., Zaufel A., Schlager H., Obermayer‐Pietsch B., Fickert P., and Zollner G., “Bile Acids and Glucocorticoid Metabolism in Health and Disease,” Biochimica et Biophysica Acta—Molecular Basis of Disease
1865 (2019): 243–251.
</cite> [<a href="https://doi.org/10.1016/j.bbadis.2018.08.001" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30463692/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochimica%20et%20Biophysica%20Acta%E2%80%94Molecular%20Basis%20of%20Disease&amp;title=Bile%20Acids%20and%20Glucocorticoid%20Metabolism%20in%20Health%20and%20Disease&amp;author=V.%20Theiler%E2%80%90Schwetz&amp;author=A.%20Zaufel&amp;author=H.%20Schlager&amp;author=B.%20Obermayer%E2%80%90Pietsch&amp;author=P.%20Fickert&amp;volume=1865&amp;publication_year=2019&amp;pages=243-251&amp;pmid=30463692&amp;doi=10.1016/j.bbadis.2018.08.001&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0017">
<span class="label">17.</span><cite>
Acevedo J., Fernández J., Prado V., et al., “Relative Adrenal Insufficiency in Decompensated Cirrhosis: Relationship to Short‐Term Risk of Severe Sepsis, Hepatorenal Syndrome, and Death,” Hepatology
58 (2013): 1757–1765.
</cite> [<a href="https://doi.org/10.1002/hep.26535" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23728792/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Relative%20Adrenal%20Insufficiency%20in%20Decompensated%20Cirrhosis:%20Relationship%20to%20Short%E2%80%90Term%20Risk%20of%20Severe%20Sepsis,%20Hepatorenal%20Syndrome,%20and%20Death&amp;author=J.%20Acevedo&amp;author=J.%20Fern%C3%A1ndez&amp;author=V.%20Prado&amp;volume=58&amp;publication_year=2013&amp;pages=1757-1765&amp;pmid=23728792&amp;doi=10.1002/hep.26535&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0018">
<span class="label">18.</span><cite>
Piano S., Favaretto E., Tonon M., et al., “Including Relative Adrenal Insufficiency in Definition and Classification of Acute‐On‐Chronic Liver Failure,” Clinical Gastroenterology and Hepatology
18 (2020): 1188–1196. e3.
</cite> [<a href="https://doi.org/10.1016/j.cgh.2019.09.035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31589973/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clinical%20Gastroenterology%20and%20Hepatology&amp;title=Including%20Relative%20Adrenal%20Insufficiency%20in%20Definition%20and%20Classification%20of%20Acute%E2%80%90On%E2%80%90Chronic%20Liver%20Failure&amp;author=S.%20Piano&amp;author=E.%20Favaretto&amp;author=M.%20Tonon&amp;volume=18&amp;publication_year=2020&amp;pages=1188-1196&amp;pmid=31589973&amp;doi=10.1016/j.cgh.2019.09.035&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0019">
<span class="label">19.</span><cite>
Bernal W., Karvellas C., Saliba F., et al., “Review Intensive Care Management of Acute‐On‐Chronic Liver Failure,” Journal of Hepatology
75 (2021): S163–S177.
</cite> [<a href="https://doi.org/10.1016/j.jhep.2020.10.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34039487/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Hepatology&amp;title=Review%20Intensive%20Care%20Management%20of%20Acute%E2%80%90On%E2%80%90Chronic%20Liver%20Failure&amp;author=W.%20Bernal&amp;author=C.%20Karvellas&amp;author=F.%20Saliba&amp;volume=75&amp;publication_year=2021&amp;pages=S163-S177&amp;pmid=34039487&amp;doi=10.1016/j.jhep.2020.10.024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0020">
<span class="label">20.</span><cite>
Nanchal R., Subramanian R., Karvellas C. J., et al., “Guidelines for the Management of Adult Acute and Acute‐On‐Chronic Liver Failure in the ICU: Cardiovascular, Endocrine, Hematologic, Pulmonary and Renal Considerations: Executive Summary,” Critical Care Medicine
48 (2020): 415–419.
</cite> [<a href="https://doi.org/10.1097/CCM.0000000000004193" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32058375/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Critical%20Care%20Medicine&amp;title=Guidelines%20for%20the%20Management%20of%20Adult%20Acute%20and%20Acute%E2%80%90On%E2%80%90Chronic%20Liver%20Failure%20in%20the%20ICU:%20Cardiovascular,%20Endocrine,%20Hematologic,%20Pulmonary%20and%20Renal%20Considerations:%20Executive%20Summary&amp;author=R.%20Nanchal&amp;author=R.%20Subramanian&amp;author=C.%20J.%20Karvellas&amp;volume=48&amp;publication_year=2020&amp;pages=415-419&amp;pmid=32058375&amp;doi=10.1097/CCM.0000000000004193&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0021">
<span class="label">21.</span><cite>
European Association for the Study of the Liver
, “EASL Clinical Practice Guidelines on Acute‐on‐Chronic Liver Failure,” Journal of Hepatology
79 (2023): 461–491.
</cite> [<a href="https://doi.org/10.1016/j.jhep.2023.04.021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37364789/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Hepatology&amp;title=EASL%20Clinical%20Practice%20Guidelines%20on%20Acute%E2%80%90on%E2%80%90Chronic%20Liver%20Failure&amp;volume=79&amp;publication_year=2023&amp;pages=461-491&amp;pmid=37364789&amp;doi=10.1016/j.jhep.2023.04.021&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0022">
<span class="label">22.</span><cite>
Tsai M. H., Peng Y. S., Chen Y. C., et al., “Adrenal Insufficiency in Patients With Cirrhosis, Severe Sepsis and Septic Shock,” Hepatology
43 (2006): 673–681.
</cite> [<a href="https://doi.org/10.1002/hep.21101" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16557538/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Adrenal%20Insufficiency%20in%20Patients%20With%20Cirrhosis,%20Severe%20Sepsis%20and%20Septic%20Shock&amp;author=M.%20H.%20Tsai&amp;author=Y.%20S.%20Peng&amp;author=Y.%20C.%20Chen&amp;volume=43&amp;publication_year=2006&amp;pages=673-681&amp;pmid=16557538&amp;doi=10.1002/hep.21101&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0023">
<span class="label">23.</span><cite>
Nandish H. K., Arun C. S., Nair H. R., Gopalakrishna R., Kumar H., and Venu R. P., “Adrenal Insufficiency in Decompensated Cirrhotic Patients Without Infection: Prevalence, Predictors and Impact on Mortality,” Journal of the Royal College of Physicians of Edinburgh
49 (2019): 277–281.
</cite> [<a href="https://doi.org/10.4997/JRCPE.2019.405" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31808452/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20Royal%20College%20of%20Physicians%20of%20Edinburgh&amp;title=Adrenal%20Insufficiency%20in%20Decompensated%20Cirrhotic%20Patients%20Without%20Infection:%20Prevalence,%20Predictors%20and%20Impact%20on%20Mortality&amp;author=H.%20K.%20Nandish&amp;author=C.%20S.%20Arun&amp;author=H.%20R.%20Nair&amp;author=R.%20Gopalakrishna&amp;author=H.%20Kumar&amp;volume=49&amp;publication_year=2019&amp;pages=277-281&amp;pmid=31808452&amp;doi=10.4997/JRCPE.2019.405&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0024">
<span class="label">24.</span><cite>
Arabi Y. M., Aljumah A., Dabbagh O., et al., “Low‐Dose Hydrocortisone in Patients With Cirrhosis and Septic Shock: A Randomized Controlled Trial,” Canadian Medical Association Journal
182 (2010): 1971–1977.
</cite> [<a href="https://doi.org/10.1503/cmaj.090707" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3001503/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21059778/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Canadian%20Medical%20Association%20Journal&amp;title=Low%E2%80%90Dose%20Hydrocortisone%20in%20Patients%20With%20Cirrhosis%20and%20Septic%20Shock:%20A%20Randomized%20Controlled%20Trial&amp;author=Y.%20M.%20Arabi&amp;author=A.%20Aljumah&amp;author=O.%20Dabbagh&amp;volume=182&amp;publication_year=2010&amp;pages=1971-1977&amp;pmid=21059778&amp;doi=10.1503/cmaj.090707&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0025">
<span class="label">25.</span><cite>
Vu T., Vallabh M., and Laine G., “Adrenal Insufficiency and Response to Stress Dose Hydrocortisone in Patients With Cirrhosis and Vasopressor Dependency Using Cirrhosis‐Specific Cortisol Thresholds,” Annals of Pharmacotherapy
54 (2020): 742–749.
</cite> [<a href="https://doi.org/10.1177/1060028019900266" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31928081/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Pharmacotherapy&amp;title=Adrenal%20Insufficiency%20and%20Response%20to%20Stress%20Dose%20Hydrocortisone%20in%20Patients%20With%20Cirrhosis%20and%20Vasopressor%20Dependency%20Using%20Cirrhosis%E2%80%90Specific%20Cortisol%20Thresholds&amp;author=T.%20Vu&amp;author=M.%20Vallabh&amp;author=G.%20Laine&amp;volume=54&amp;publication_year=2020&amp;pages=742-749&amp;pmid=31928081&amp;doi=10.1177/1060028019900266&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0026">
<span class="label">26.</span><cite>
Majumdar A., Bailey M., Kemp W. M., Bellomo R., Roberts S. K., and Pilcher D., “Declining Mortality in Critically Ill Patients With Cirrhosis in Australia and New Zealand Between 2000 and 2015,” Journal of Hepatology
67 (2017): 1185–1193.
</cite> [<a href="https://doi.org/10.1016/j.jhep.2017.07.024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28802877/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Hepatology&amp;title=Declining%20Mortality%20in%20Critically%20Ill%20Patients%20With%20Cirrhosis%20in%20Australia%20and%20New%20Zealand%20Between%202000%20and%202015&amp;author=A.%20Majumdar&amp;author=M.%20Bailey&amp;author=W.%20M.%20Kemp&amp;author=R.%20Bellomo&amp;author=S.%20K.%20Roberts&amp;volume=67&amp;publication_year=2017&amp;pages=1185-1193&amp;pmid=28802877&amp;doi=10.1016/j.jhep.2017.07.024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0027">
<span class="label">27.</span><cite>
Meersseman P., Langouche L., du Plessis J., et al., “The Intensive Care Unit Course and Outcome in Acute‐On‐Chronic Liver Failure Are Comparable to Other Populations,” Journal of Hepatology
69 (2018): 803–809.
</cite> [<a href="https://doi.org/10.1016/j.jhep.2018.04.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29730473/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Hepatology&amp;title=The%20Intensive%20Care%20Unit%20Course%20and%20Outcome%20in%20Acute%E2%80%90On%E2%80%90Chronic%20Liver%20Failure%20Are%20Comparable%20to%20Other%20Populations&amp;author=P.%20Meersseman&amp;author=L.%20Langouche&amp;author=J.%20du%20Plessis&amp;volume=69&amp;publication_year=2018&amp;pages=803-809&amp;pmid=29730473&amp;doi=10.1016/j.jhep.2018.04.025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0028">
<span class="label">28.</span><cite>
Evans L., Rhodes A., Alhazzani W., et al., “Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021,” Critical Care Medicine
49 (2021): e1063–e1143.
</cite> [<a href="https://doi.org/10.1097/CCM.0000000000005337" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34605781/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Critical%20Care%20Medicine&amp;title=Surviving%20Sepsis%20Campaign:%20International%20Guidelines%20for%20Management%20of%20Sepsis%20and%20Septic%20Shock%202021&amp;author=L.%20Evans&amp;author=A.%20Rhodes&amp;author=W.%20Alhazzani&amp;volume=49&amp;publication_year=2021&amp;pages=e1063-e1143&amp;pmid=34605781&amp;doi=10.1097/CCM.0000000000005337&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0029">
<span class="label">29.</span><cite>
Weil D., Levesque E., McPhail M., et al., “Prognosis of Cirrhotic Patients Admitted to Intensive Care Unit: A Meta‐Analysis,” Annals of Intensive Care
7 (2017): 33.
</cite> [<a href="https://doi.org/10.1186/s13613-017-0249-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5359266/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28321803/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annals%20of%20Intensive%20Care&amp;title=Prognosis%20of%20Cirrhotic%20Patients%20Admitted%20to%20Intensive%20Care%20Unit:%20A%20Meta%E2%80%90Analysis&amp;author=D.%20Weil&amp;author=E.%20Levesque&amp;author=M.%20McPhail&amp;volume=7&amp;publication_year=2017&amp;pages=33&amp;pmid=28321803&amp;doi=10.1186/s13613-017-0249-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0030">
<span class="label">30.</span><cite>
Arabi Y. M., Dara S. I., Memish Z., et al., “Antimicrobial Therapeutic Determinants of Outcomes From Septic Shock Among Patients With Cirrhosis,” Hepatology
56 (2012): 2305–2315.
</cite> [<a href="https://doi.org/10.1002/hep.25931" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3556696/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22753144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Antimicrobial%20Therapeutic%20Determinants%20of%20Outcomes%20From%20Septic%20Shock%20Among%20Patients%20With%20Cirrhosis&amp;author=Y.%20M.%20Arabi&amp;author=S.%20I.%20Dara&amp;author=Z.%20Memish&amp;volume=56&amp;publication_year=2012&amp;pages=2305-2315&amp;pmid=22753144&amp;doi=10.1002/hep.25931&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0031">
<span class="label">31.</span><cite>
Fernández J., Acevedo J., Wiest R., et al., “Bacterial and Fungal Infections in Acute‐On‐Chronic Liver Failure: Prevalence, Characteristics and Impact on Prognosis,” Gut
67 (2017): 1870–1880.
</cite> [<a href="https://doi.org/10.1136/gutjnl-2017-314240" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28847867/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Gut&amp;title=Bacterial%20and%20Fungal%20Infections%20in%20Acute%E2%80%90On%E2%80%90Chronic%20Liver%20Failure:%20Prevalence,%20Characteristics%20and%20Impact%20on%20Prognosis&amp;author=J.%20Fern%C3%A1ndez&amp;author=J.%20Acevedo&amp;author=R.%20Wiest&amp;volume=67&amp;publication_year=2017&amp;pages=1870-1880&amp;pmid=28847867&amp;doi=10.1136/gutjnl-2017-314240&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0032">
<span class="label">32.</span><cite>
Wentworth B. J. and Siragy H. M., “Adrenal Insufficiency in Cirrhosis,” Journal of the Endocrine Society
6 (2022): 1–11.</cite> [<a href="https://doi.org/10.1210/jendso/bvac115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9408036/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36033971/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20the%20Endocrine%20Society&amp;title=Adrenal%20Insufficiency%20in%20Cirrhosis&amp;author=B.%20J.%20Wentworth&amp;author=H.%20M.%20Siragy&amp;volume=6&amp;publication_year=2022&amp;pages=1-11&amp;pmid=36033971&amp;doi=10.1210/jendso/bvac115&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="liv70257-bib-0033">
<span class="label">33.</span><cite>
Venkatesh B., Prins J., Torpy D., et al., “Relative Adrenal Insufficiency in Sepsis: Match Point or Deuce?,” Critical Care and Resuscitation
8 (2006): 376–380.
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/17227279/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Critical%20Care%20and%20Resuscitation&amp;title=Relative%20Adrenal%20Insufficiency%20in%20Sepsis:%20Match%20Point%20or%20Deuce?&amp;author=B.%20Venkatesh&amp;author=J.%20Prins&amp;author=D.%20Torpy&amp;volume=8&amp;publication_year=2006&amp;pages=376-380&amp;pmid=17227279&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p>
<strong>Data S1</strong> liv70257‐sup‐0001‐DataS1.docx.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12320571/bin/LIV-45-0-s002.docx" data-ga-action="click_feat_suppl" class="usa-link">LIV-45-0-s002.docx</a><sup> (828.6KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p"><p>
<strong>Data S2</strong> liv70257‐sup‐0002‐DataS2.pdf.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12320571/bin/LIV-45-0-s001.pdf" data-ga-action="click_feat_suppl" class="usa-link">LIV-45-0-s001.pdf</a><sup> (1.1MB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Liver International are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1111/liv.70257"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/LIV-45-0.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (581.6 KB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12320571/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12320571/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12320571%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12320571/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12320571/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12320571/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40757786/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12320571/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40757786/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12320571/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12320571/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="qFVyj4CgX4UvRu4iuXWVZn9znuwn7MmYbOef8qW9cyF2jaKLW5Q1EB6ydm2BDQZr">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
